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ABSTRACT 
 
The typical manifestations of the rheumatoid hand are ulnar drift of the knuckle 
joints and palmar subluxation of the wrist joint. The wrist collapse facilitates a 
progression of metacarpophalangeal (MCP) joint deformities, and thus in operative 
treatment the wrist joint deformity is corrected before MCP joint surgery. Total 
arthrodesis of the wrist and silicone arthroplasty of the MCP joints have been the 
gold standards for long in rheumatoid hand surgery. The main problem of the total 
fusion is the loss of motion of the wrist joint, and after silicone MCP arthroplasty 
the breakage of the implants and deterioration of the clinical outcome in long-term 
follow-up. 
The aim of this dissertation was to study the effect of partial radiocarpal 
arthrodesis on rheumatoid hand alignment, function and pain, and to analyse the 
biocompatibility and clinical results of a novel bioabsorbable 96L/4D poly-L/D-
lactide copolymer (PLDLA) implant, also to compare the outcome of PLDLA 
implant arthroplasty with that of the conventional silicone Swanson prosthesis.  
In partial radiocarpal arthrodesis Study (I) 23 patients and 26 wrists (Larsen II-
III) were recruited for a prospective non-randomised study and clinical and 
radiological evaluation were performed at a mean of 5.8-year follow-up. In Studies 
II and III 23 consecutive patients (80 joints) undergoing MCP arthroplasty using a 
novel bioabsorbable PLDLA implant were enrolled, and clinical and radiological 
evaluation was made at minimum 1-year follow-up and at mean 59 months after 
surgery, the latter follow-up time exceeding the resorption time of the implant. In a 
randomised clinical Study IV, the outcome of the PLDLA implant was compared to 
the outcome of the conventional silicone Swanson prosthesis in 52 patients (53 
hands and 175 joints) at a mean follow-up of 2 years.  In all studies only patients 
with an inflammatory arthritis diagnosis were included. 
Partial radiocarpal arthrodesis gave good pain relief and subjective patient 
satisfaction was good, 17 out of 23 patients were totally pain-free and satisfaction 
was excellent or good in 20 patients. The active range of motion (63°) at final 
follow-up enables most of the activities of daily living. Correction of the ulnar 
translocation malalignment was achieved and maintained. No serious adverse events 
were observed after MCP joint arthroplasty with the novel bioabsorbable PLDLA 
implant. The clinical results (pain relief, range of motion (ROM), correction of the 
ulnar deviation and volar subluxation) obtained using PLDLA implants in the non-
randomised studies (II-III) were comparable to earlier silicone arthroplasty results, 
and the clinical outcome of the Study III with the follow-up exceeding the 
resorption time of the implant did not differ substantially from the outcome of 
Studies II and IV with follow-up time under the bioabsorbtion time of the implant. 
In the randomised Study IV improvement in pain relief, ROM, power grip and 
correction of the ulnar deviation were similar in the PLDLA and Swanson groups. 
Palmar subluxation improved significantly in both groups, but at follow-up, palmar 
dislocation was observed more frequently in the PLDLA group (44 joints) than in 
the Swanson group (10 joints).  
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TIIVISTELMÄ 
 
Reuman aiheuttamia tyyppimuutoksia kädessä ovat rystysnivelten ulnaarideviaatio 
ja/tai palmaarisubluksaatio virheasento sekä ranteen palmaari- ja ulnaari-
subluksaatio. Ranteen virheasento edesauttaa rystysmuutosten kehittymistä ja siksi 
ranteen virheasento korjataan ennen rystysnivelten leikkausta. Reumakäden 
yleisimpiä leikkauksia ovat pitkään olleet rannenivelen kokoluudutus ja 
rystysnivelten tekonivelleikkaus silikoniproteesilla. Ranteen 
kokoluudutusleikkauksen väistämätön haitta on rannenivelen liikkeen 
menettäminen. Silikonitekonivelten hajoaminen ja saavutetun leikkaustuloksen 
huononeminen vuosien saatossa ovat tavanomaisia ongelmia 
rystystekonivelleikkauksen jälkeen.  
Väitöskirjatutkimuksen tarkoituksena oli ensinnäkin selvittää ranteen 
radiokarpaalisen osaluudutusleikkauksen vaikutusta reumakäden asentoon, 
toimintaan ja kipuun. Toisekseen selvitettiin uuden biokorvautuvan 
maitohappopohjaisen tekonivelen (96L/4D poly-L/D-lactide) soveltuvuutta ja 
tuloksia reumapotilaiden rystystekonivelleikkauksissa sekä verrattiin 
biokorvautuvan tekonivelen tuloksia perinteiseen Swanson silikonitekoniveleen. 
Prospektiiviseen ei-randomisoituun ranteen radiokarpaali 
osaluudutustutkimukseen (I) rekrytoitiin 23 potilasta käsittäen 26 Larsen II-III 
destruoitunutta rannetta. Kliiniset ja radiologiset tulokset 20 potilaasta ja 23 
ranteesta arvioitiin keskimäärin 5.8 vuotta leikkauksesta. Tutkimusten II ja III 
potilasmateriaali muodostui 23 peräkkäisestä potilaasta (80 nivelestä), joille tehtiin 
rystystekonivelleikkaus uudella biokorvautuvalla PLDLA tekonivelellä. Kliininen ja 
radiologinen arvio tehtiin vähintään yksi vuosi leikkauksesta ja keskimäärin 59 
kuukautta leikkauksesta, jolloin biokorvautuva materiaali aikaisempien tutkimusten 
mukaan on poistunut elimistöstä. Randomisoidussa kliinisessä tutkimuksessa (IV) 
PLDLA implantilla tehtyjen rystystekonivelleikkausten tuloksia verrattiin 
perinteisellä Swanson silikonitekonivelellä tehtyjen leikkausten tuloksiin 52 
potilaalla (53 kättä ja 175 niveltä) keskimäärin kaksi vuotta leikkauksesta.  
Radiokarpaalisella ranteen osaluudutusleikkauksella saavutettiin hyvä kivun 
lievitys, täysin kivuttomia oli 17 potilasta 23 potilaasta. Tyytyväisyys 
leikkaustulokseen oli erinomainen tai hyvä 20 potilaalla. Saavutettu keskimääräinen 
aktiivi liikeala (63°) mahdollistaa suuren osa päivittäisistä askareista. Ulnaarinen 
siirtymä korjaantui hyvin leikkauksella ja tulos säilyi seuranta-ajan.  
Uudella biokorvautuvalla PLDLA tekonivelellä ei todettu vakavia 
haittavaikutuksia. Kliiniset tulokset, käsittäen kivun lievittymisen, liikealan, 
ulnaarideviaatiovirheasennon korjaantumisen ja palmaarisen subluksaation 
korjaantumisen, PLDLA implantilla olivat ei-randomisoiduissa tutkimuksissa (II-
III) vertailukelpoisia aikaisemmin silikonitekonivelillä julkaistuihin tuloksiin. 
Tutkimuksen III, jonka seuranta-aika ylitti biokorvautuvan materiaalin 
resorptioajan, tulokset eivät eronneet merkittävästi lyhyemmän seuranta-ajan 
tutkimusten (II ja IV) tuloksista. Randomisoidussa tutkimuksessa (IV) kivun 
helpottumisessa, liikealassa, puristusvoimassa tai ulnaarideviaation 
korjaantumisessa ei ollut eroa PLDLA ja Swanson ryhmien välillä.   Palmaarinen 
subluksaatio korjaantui molemmissa ryhmissä, mutta palmaarista dislokaatiota oli 
PLDLA ryhmässä enemmän (44 nivelessä) kuin Swanson ryhmässä (10 nivelessä).  
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INTRODUCTION 
 
The typical rheumatoid hand deformity, consisting of palmar and ulnar subluxation 
of the wrist, ulnar drift and/or palmar subluxation of the MCP joints and swan neck 
or boutonnière deformity of the fingers, has been a frequent manifestation in 
rheumatoid arthritis (RA) patients with long-standing erosive disease. The wrist 
malalignment leads to the deformity of the MCP joints (Pahle & Raunio, 1969; 
Taleisnik, 1989; Shapiro, 1996; van Vugt, van Jaarsveld, Hofman, Helders, & 
Bijlsma, 1999). The destructive changes caused by RA are often significant and the 
rheumatoid hand disease can even pose a threat to independence in self-care (Pap, 
Angst, Herren, Schwyzer, & Simmen, 2003; Ghattas, Mascella, & Pomponio, 2005; 
Papp, Athwal, & Pichora, 2006). The aims of surgical intervention of the 
rheumatoid hand are pain relief, restoration of function, interruption of the 
mechanisms responsible for the joint destruction, correction of deformities, 
improvement in the appearance of the hand and in some cases protection against 
further destruction (Simmen, Bogoch, & Goldhahn, 2008; Trieb, 2008). 
The surgical treatment of the rheumatoid hand needs to be started in the wrist 
joint because of the effect of the wrist malalignment on the development of ulnar 
drift in the knuckle joints.  RA of the wrist typically begins in the radiocarpal joint, 
at the same time when the cartilage and  motion of the midcarpal joint are preserved, 
which enables the use of partial radiocarpal arthrodesis operation as an early 
treatment of the rheumatoid wrist (J.K. Stanley & Boot, 1989; Arimitsu, Murase, 
Hashimoto, Oka, Sugamoto, Yoshikawa, & Moritomo, 2007). Pain alleviation is 
well achieved with radiocarpal arthrodesis, and the subjective satisfaction is 
excellent or good in 74% to 87% of cases (Linscheid & Dobyns, 1985; Chamay & 
Della Santa, 1991; Gaulke, Suppelna, Hildebrand, Citak, Hufner, & Krettek, 2010). 
The ROM of the wrist maintained after radiocarpal arthrodesis varies widely 
between studies. A decrease in the wrist motion in all directions, but significant only 
for wrist flexion, has been noted in many studies (Borisch & Haussmann, 2002; 
Ishikawa, Murasawa, & Nakazono, 2005; Masuko, Iwasaki, Ishikawa, Kato, & 
Minami, 2009). In studies with a five-year follow-up or more, as many as half of the 
cases have been reported to develop changes in the midcarpal joint after radiocarpal 
arthrodesis (Borisch & Haussmann, 2002; Ishikawa et al., 2005). 
MCP joint arthroplasty is indicated in advanced stages of destruction associated 
with pain or functional impairment. The reconstructive surgery of rheumatoid MCP 
joints was started with interposition arthroplasties using patient’s own tissues as a 
spacer (Vainio, Reiman, & Pulkki, 1967; Tupper, 1989). Many prosthetic designs 
have been introduced to MCP joint replacement over the last 50 years, but due to the 
high rate of implant fractures and dislocations, bone loss or recurrence of the ulnar 
drift, many of the designs have been withdrawn from the market (Wilson & 
Carlblom, 1989; Linscheid, 2000; Merolli, 2009). The one-piece silicone implant 
designed by Swanson in the 1960’s has remained for several decades the joint 
replacement of choice for the MCP joints in RA patients. The active ROM after 
silicone MCP arthroplasty varies from 27° to 56°, and it is either slightly improved 
from the preoperative ROM or more often sustained at the preoperative level. 
Typically the extension lag is improved whereas the flexion arc is diminished. The 
correction of the ulnar deviation is regularly achieved, and the postoperative 
deviation varies from 4° to 23°.  
12 
Clinical and radiological benefits of silicone MCP joint arthroplasty are often lost 
in long-term follow-up. Only 28% of patients were pain free and only 38% were 
satisfied with function in the study by Goldfarb and Stern (2003) at 14-year follow-
up. Wilson et al. (1993) reported over 20 degrees recurrence of ulnar deviation in 
43% of cases after 14-year follow-up. Survival at five years using revision surgery 
as an endpoint has been reported to be 92-97% and at 10 years 83-90% (Hansraj, 
Ashworth, Ebramzadeh, Todd, Griffin, Ashley, & Cardilli, 1997; Trail, Martin, 
Nuttall, & J.K. Stanley, 2004; Parkkila, Belt, Hakala, Kautiainen, & Leppilahti, 
2006). However, using fracture of the implant as the end point, survival was only 
58% at 10 years (Trail et al., 2004). Osteolysis around the silicone implant is 
common. In a randomised controlled trial (RCT), comparing Swanson and Sutter 
prostheses, only 60% of the metacarpals in the Swanson group and 23% in the 
Sutter group were free of osteolytic changes at 58-month follow-up. Osteolysis 
perforating the cortex was reported in 5% of Swanson cases and in 30% of Sutter 
cases (Parkkila, Belt, Hakala, Kautiainen, & Leppilahti, 2005).  
Our first study evaluates outcomes of partial radiocarpal arthrodesis in RA 
patients. The usability of the novel bioabsorbable 96L/4D poly-L/D-lactide 
copolymer joint scaffold in MCP joint arthroplasty was evaluated in Studies II-IV. 
The first study was an open clinical trial (Study II) to investigate short-term 
biocompatibility and function of PLDLA implants. The third study evaluates clinical 
and radiological outcomes of PLDLA implants at a mean of 59 months after 
surgery, a follow-up time which exceeds the resorption time of the implant. The 
results of the PLDLA implants were compared with those of the conventional 
Swanson silicone implant in the randomised clinical trial in Study IV.  
13 
REVIEW OF THE LITERATURE 
 
 
1. Rheumatoid arthritis 
 
Natural course of RA is persistant inflammation which leads to destruction of 
synovial joints. Loss of functional capacity in daily living, work disability, and 
premature death are severe consequences of untreated RA. The joint involvement in 
RA appears in a typical distribution, the small joints in the hands and feet being 
most often symmetrically involved. The majority of patients are positive for 
rheumafactor (RF) and/or cyclic citrullinated peptide antibody (CCP). Genetic and 
environmental factors are involved in the pathogenesis, but the initiating cause 
remains unknown (Isenberg, Maddison, Woo, Glass, & Breedveld, 2004).  
The prevalence of RA in Finland is about 0.8%, and incidence about 40/100,000 
of the adult population. Mean age at diagnosis has increased, according to the study 
by Aho and co-workers by 7.6 years from 1975 to 1990 (Kaipiainen-Seppanen, Aho, 
Isomaki, & Laakso, 1996; Aho, Kaipiainen-Seppanen, Heliovaara, & Klaukka, 
1998.) RA affects more women than men: 70% of patients with RA are women. 
The multifactorial and still unclear pathogenesis is under active research. 
Rheumatoid synovial fluid and synovial membrane in diarthroidal joints have been 
observed to contain a wide variety of activated cell types like neutrophils, dendritic 
cells, T- and B- lymphocytes and macrophages, which produce a variety of 
cytokines. The cytokines, the best known being tumour necrosis factor-α (TNF-α), 
interleukin-1 and other interleukins, are essential messenger molecules in many 
phases of the inflammatory process in RA (Harris, 1990; Isenberg et al., 2004).  
Chronic synovial inflammation leads in the long term to destructive changes in 
the joints and periarticular tissues, resulting in pain, stiffness and loss of function. 
Systemic extra-articular features related to RA include amyloidosis, 
lymphadenopathy, rheumatoid nodules and vasculitis and may cause morbidity in 
patients. RA has a wide clinical spectrum, which varies from mild joint symptoms to 
severe inflammation and damage in multiple joints (Isenberg et al., 2004; Trieb, 
2008.) Recent studies show that aggressive treatment with a combination of 
synthetic disease-modifying antirheumatic drugs (DMARDs) and biologics starting 
already in the early disease can retard the radiologic progression of the disease 
(Korpela, Laasonen, Hannonen, Kautiainen, Leirisalo-Repo, Hakala, Paimela, 
Blafield, Puolakka, & Mottonen, 2004; Kourbeti & Boumpas, 2005; Rantalaiho, 
Korpela, Laasonen, Kautiainen, Jarvenpaa, Hannonen, Leirisalo-Repo, Blafield, 
Puolakka, Karjalainen, & Mottonen, 2010) .   
The increasing knowledge of the immunopathogenesis of RA has enabled the 
development of new pharmaceuticals. Transition from sequential monotherapy with 
DMARDs to a combination DMARD therapy in the 1990's and the licensing of 
biological therapies in the 2000's together with early initiation of medication have 
improved outcomes related to many long-term consequences of inflammation such 
as joint deformity, functional decline, work disability, and  premature death (Pincus, 
Sokka, & Kautiainen, 2005; Puolakka, Kautiainen, Mottonen, Hannonen, Korpela, 
Hakala, Jarvinen, Ahonen, Forsberg, & Leirisalo-Repo, 2005; Sokka, 2009). 
Declining needs for total joint replacements and other RA-related surgery has been 
reported during last decade in Western countries (Weiss, Ehlin, Montgomery, Wick, 
Stark, & Wretenberg, 2008; Kolling, Herren, Simmen, & Goldhahn, 2009; Louie & 
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Ward, 2010; Hekmat, Jacobsson, Nilsson, Petersson, Robertsson, Garellick, & 
Turesson, 2011; Khan & Sokka, 2011).   
 
 
 
2. Rheumatoid hand 
 
In RA patients the metacarpophalangeal (MCP), proximal interphalangeal (PIP), and 
wrist joints are involved early and frequently, and arthritic involvement in proximal 
joints has an influence on the distal joints as well. This involvement is collectively 
defined as ‘rheumatoid hand disease’ (Straub, 1959; Abboud, Beredjiklian, & 
Bozentka, 2003; Ghattas et al., 2005). Classically the rheumatoid hand deformity is 
composed of palmar and ulnar subluxations of the wrist, ulnar drift and/or palmar 
subluxation of the MCP joints and Swan neck or boutonnière deformity of the 
fingers (D. Stanley & Norris, 1988). 
  
Figure 1.  Clinical and radiological picture of rheumatoid hand 
 
 
In patients who were diagnosed RA in the 1970’s, before treatment with 
DMARD combinations and biologics, wrist involvement was reported to affect up 
to 50% of patients within the first 2 years after the onset of the disease, increasing to 
>90% after 10 years, and in the majority of the patients this involvement was 
bilateral (Hamalainen, Kammonen, Lehtimaki, Nurmi, Repo, Ikavalko, Niskanen, & 
Kaarela, 1992; Trieb, 2008). In the study by Belt and co-workers (1998) assessing 
radiological destruction in the hand joints 20 years after the diagnosis of 
seropositive RA destructive changes were more severe proximally and diminished 
distally, in contrast to osteoarthritis. Rheumatoid hand disease can significantly 
affect the activities of daily living (ADL), and may be a threat to independence in 
self-care, thus representing a major problem for RA patients (Ghattas et al., 2005; 
Pap et al., 2003).  
The aggressive treatment strategy to treat patients with RA early with tight 
control toward remission combined with new medications has improved patients’ 
clinical status and joint destructions have decreased significantly in comparison with 
previous decades (Pincus et al., 2005; Rantalaiho et al. 2010). Concomitantly with 
improved medical treatment studies suggesting decreasing tendency of rheumatoid 
hand surgery have recently been published from Western countries (Weiss et al., 
2008; Kolling et al., 2009; Louie & Ward, 2010). 
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2.1 Pathophysiology 
The synovial inflammation and formation of pannus tissue causes cartilage and 
subchondral bone damage and destruction in the joints. The inflammation process 
and intra-articular pressure stretches the joint capsule and periarticular structures, 
including ligaments and tendons, causing joint instability and deterioration of the 
function (D. Stanley & Norris, 1988; Trieb, 2008). The joint laxity induces 
subluxation, which in association with imbalance of forces leads to progressive joint 
damage and deformity (J.K. Stanley, 1999).  
The wrist is the key joint in rheumatoid arthritis of the hand (Taleisnik, 1989; 
Flury, Herren, & Simmen, 1999). RA can affect the three main joint systems of the 
wrist: the distal radioulnar joint (DRUJ), the radiocarpal joint and less frequently the 
midcarpal joint (D. Stanley & Norris, 1988, Tubiana, 1998; Blomqvist, Haglund, 
Knutson, Lundborg, Marké, Nived, Rydholm, Sollerman, & Svensson, 2000). 
Inflammatory synovitis and fluid weaken the radiocarpal ligaments leading to a loss 
of ligamentous support and carpal collapse. The carpal bones translocate in ulnar, 
proximal and palmar directions, partially due to the palmar and ulnar inclination of 
the radius. Palmar flexion of the scaphoid often occurs and contributes to the ulnar 
translocation and radial deviation of the carpus (Linscheid & Dobyns, 1971; 
Taleisnik, 1989). Synovitis in the DRUJ joint weakens the triangular fibrocartilage 
complex (TFCC) and leads to sliding of the extensor carpi ulnaris (ECU) tendon in a 
palmar direction, inducing ulnar translocation and supination of the carpus. The 
ulnar head is dorsally prominent, called caput ulnae syndrome, which at worst can 
lead to extensor tendon ruptures of the overriding tendons. The cartilage and bony 
destruction caused by the arthritic process together with the dislocation of the wrist 
leads to loss of the height of the carpus. All these changes together reduce the 
effectiveness of the extrinsic finger muscles, crossing the wrist joint (D. Stanley & 
Norris, 1988; Taleisnik, 1989; Shapiro, 1996; Tubiana, 1998; Arimitsu et al., 2007; 
Little & Stern, 2007.) 
Ulnar drift, malalignment of the knuckle joints, is perhaps the most characteristic 
manifestation of the rheumatoid hand (Blomqvist et al., 2000). The multifactorial 
pathophysiology of MCP joints in RA can be divided into three main elements: 
anatomical causes, causes linked to rheumatoid arthritis pathology and indirect 
causes (Egloff, 1998). The MCP joints have three planes of motion, extension-
flexion, radial-ulnar deviation and axial rotation. The main stabilizers of the MCP 
joints, radial and ulnar collateral ligaments, are tight only in flexion. This diminishes 
the inherent stability of these joints (Stirrat, 1996; Feldon, Terrono, Nalebuff, & 
Millender, 2005). In many hand activities the MCP joints are used not in pure 
flexion but together with ulnar deviation and rotation (Flatt, 1996).The metacarpal 
heads display anatomically a slight ulnar slope, and the ulnar collateral ligament has 
been reported to be stronger than the radial collateral ligament, which both 
contribute to the ulnar drift (Stirrat, 1996; Egloff, 1998; Abboud et al., 2003; Feldon 
et al., 2005). The capsular-ligamentous laxity and osteo-cartilaginous destruction of 
the MCP joints caused by the arthritis are major elements in the pathophysiology of 
ulnar drift in RA. The weakening of the sagittal bands enables the extensor tendon 
to migrate in an ulnar direction into the valleys between the metacarpal heads, 
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which induces an imbalance of the extrinsic tendon forces (Wilson & Carlblom, 
1989; Abboud et al., 2003; Little & Stern, 2007).  Synovitis also attenuates the 
flexor tendon sheets, which transfers the pulling forces in a palmar direction. The 
shift of the position of the tendons steadily increases the aberrant pull on the joint, 
and the condition becomes self-perpetuating (Flatt, 1996). As the deformity 
progresses the MCP joints become set in a flexed position as the ulnar intrinsics and 
abductor digiti minimi muscles gradually tighten (Stirrat, 1996).  
In the 1960’s Shapiro showed that rheumatic wrist collapse leads to radial 
deviation of the metacarpals and subsequently to ulnar drift of the MCP joints. Pahle 
and Raunio (1969) confirmed this observation in a study of fused rheumatoid wrists. 
A significant positive correlation between the angles of radial deviation of the wrist 
and ulnar deviation of the fingers was also reported in a study by van Vugt and co-
workers (1999).  
 
 
Figure 2.  Mechanical pathophysiology of an unstable rheumatoid hand 
 
   
 
 
The question is still if wrist collapse can initiate dislocation of the rheumatoid digits, 
but at least it is clear that wrist malalignment facilitates the progression of the finger 
deformities (Taleisnik, 1989).  
Swan neck and boutonnière finger deformities arise from an imbalance of very 
complex, delicately balanced extrinsic and intrinsic tendon systems, and these 
deformities, although not unique to RA, are initiated by synovitis in RA (Rizio & 
Belsky, 1996; Feldon et al., 2005). Swan neck deformity, hyperextension at the 
proximal interphalangeal (PIP) joint with a flexion deformity at the distal 
interphalangeal (DIP) joint arises from an imbalance originating in the MCP, PIP or 
DIP joints.  Boutonnière deformity, which refers to a PIP joint in a flexion 
contracture combined with a reciprocal hyperextension of the DIP joint, is induced 
by synovitis in the PIP joint.  
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2.2 Clinical evaluation 
The rheumatoid inflammatory process itself and damage to the joint and 
periarticular soft tissue cause swelling, pain, stiffness, weakness, motion restrictions 
and  function deficiency in the hand (J. K. Stanley, 1999). In the patient’s history 
symptoms, disease activity, current medication, and previous surgical procedures 
performed to the elbow, wrist and fingers need to be recorded.  The patient-specific 
difficulties with ADL tasks requiring strength or dexterity give important 
information. Swelling, tenderness and malalignment in different joints and tendons 
are examined by inspection and palpation (Shapiro, 1996; Trieb, 2008). In the 
evaluation of functional deficit, assessments of the range of motion (ROM) in 
different joints, grip strength, pinch power and separate tendon functions are used. 
The consequences of the functional deficits in the ADL and quality of life can be 
quantified using tests simulating ADL tasks and standardized patient self-
assessments (Pap et al., 2003; Bjork, Thyberg, Haglund, & Skogh, 2006; Simmen et 
al., 2008; Trieb, 2008). Dias et al. (2009) described the ‘working space of the hand’ 
as a new concept to evaluate rheumatoid hand function. The difference between the 
flexion and extension volumes is the working space, which takes into account 
multiple deformities of the hand. The functional disability score was significantly 
related to changes in the working space as defined in this novel concept (Dias, 
Smith, Singh, & Ullah, 2009). The physical examination of the wrist and hand need 
to be bilateral and the elbow and shoulder joints of the ipsilateral side should also be 
evaluated (Abboud et al., 2003; Trieb, 2008). Tenosynovitis and bone deformities, 
which may lead to flexor or extensor tendon rupture, should be checked (Abboud et 
al., 2003). Compressive neuropathies are often overlooked, because sensory 
disturbances may be regarded as a minor annoyance compared to other RA-related 
problems (Moran & Bishop, 2007). 
Standardised radiographs form the basis for the evaluation of the joint destruction 
stage and localization in the rheumatoid hand. Radiographs are also the keystone in 
the evaluation of the progression of joint destruction (Shapiro, 1996). Two 
radiological scoring methods are commonly used to assess joint damage in RA. In 
the Sharp method a total of 23 joints in the hands and wrists are scored on a graded 
scale for erosions and narrowing of the joint space (Sharp, 1989). The widely used 
Larsen classification including five grades has been applied to different joints, 
which all have their individual grades (Larsen, Dale, & Eek, 1977; Larsen, 1995).  
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Figure 3.  Schematic presentation of Larsen grading 
 
  
 
In the evaluation of finger deformities and often in parallel with the radiological 
classification, a specific clinical staging is used to record the functional capacity 
(Stirrat, 1996; Abboud et al., 2003). In the evaluation of the wrist the Wrightington 
classification combines the current radiological findings and reasonable surgical 
choices at four different stages of the destruction (Hodgson, Stanley, & Muirhead, 
1989). On the basis of the radiological long-term analysis of the natural course of 
the rheumatoid wrist, Simmen and Huber (1992) described rheumatoid wrist 
involvement according to the type of destruction instead of its extent, their intention 
being to enable proper selection of surgical treatment modalities at an early stage of 
the disease. This Schulthess classification distinguishes three types of rheumatoid 
wrist involvement with different long-term courses of joint destruction. Type 1 
(ankylosis) wrists have a tendency to lose motion and may progress to a 
spontaneous fusion. The ankylosis pattern is typical for juvenile idiopathic arthritis. 
Type 2 (secondary osteoarthritis) wrists demonstrate an osteoarthritis type 
destruction with cartilage loss associated with osteophyte formation and capsule 
shrinkage and sclerosis, which all help to maintain joint stability. Patients with the 
most common type 3 (destabilization) wrist involvements develop radiocarpal 
instability on the basis of ulnar and palmar subluxation of the carpus (Simmen & 
Huber, 1992; Simmen, 1998; Flury et al., 1999). Type 3 deformity often requires 
early osseous stabilization to prevent disintegration and disability (Flury et al., 
1999). Specific radiographic parameters such as carpal height ratio (CHR), ulnar 
translocation and scapholunate dissociation have been reported to correlate with the 
Schulthess classification, contributing to the grading of the wrist into one of these 
three types (Flury et al., 1999). The weaknesses of the Schulthess classification are 
inadequate reproducibility (interobserver agreement) and a large number of cases in 
which the damage in radiographs is insufficient to reveal a type. However, it 
provides reliable identification of wrists that are at a risk of becoming severely 
unstable (Zangger, Kachura, & Bogoch, 1999).  
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2.3 Surgical treatment 
RA is a systemic disease affecting also extra-articular tissues, and its natural course 
is progressive and incurable (J. K. Stanley, 1998). RA disease progression has 
effectively been slowed by modern therapeutic drugs and active treatment strategies 
aiming at remission, and rates of RA-related surgery have reported to decrease 
during last years (Kolling et al., 2009; Louie & Ward, 2010; Hekmat et al., 2011). 
Not all patients with RA need rheumatic surgery during their lifetime, but of those 
who require surgical treatment many need several operations (Blomqvist et al., 
2000). The assessment of the need of a rheumatic patient for surgical treatment and 
the advantages, disadvantages and the sequence and timing of various surgical 
procedures are best performed by a specialized team, consisting of a rheumatologist, 
an orthopaedic and/or hand surgeon experienced in surgery for patients with RA, an 
occupational therapist, a physiotherapist and a social worker (Souter, Sheffield, 
McGullough, Meggitt, & Swann, 2002; Simmen et al., 2008).  
 
2.3.1 Indications 
There are many options for surgical intervention in the rheumatoid hand, but they all 
share common goals aiming to relieve pain, restore function and quality of life, 
interrupt the mechanisms responsible for the joint destruction, correct deformities, 
improve appearance and in some cases provide prophylaxis against further 
destruction (Simmen et al., 2008; Trieb, 2008). The surgical procedures are often 
performed on multiple interactive indications. Pain and impaired hand function are 
common indications for rheumatoid hand surgery (Blomqvist et al., 2000). Tendon 
rupture - or imminent risk thereof - should be an absolute indication for surgical 
intervention. The causes of the rupture, synovitis and mechanical compression, are 
direct risk factors for the rupture of the adjacent tendons. Synovitis stretches the 
supporting ligaments around the joint and leads to joint instability and finger 
deformities, hence if synovitis persists for 3–6 months despite optimal medical 
treatment, surgical treatment should be considered (Chung & Kotsis, 2010). The 
natural course of the disease of the joints involved should be taken into account in 
the determination of the indications for surgery and in the selection of surgical 
methods (Blomqvist et al., 2000; Simmen et al., 2008). The indications for surgery 
are strengthened if both hands are involved and in cases where improved hand 
function will permit the use of a cane for ambulation (Bogoch & Judd, 2002).  
In the study by Chung and co-workers (2006) the variable most significantly 
associated with the willingness of RA patients to choose MCP joint arthroplasty was 
decreased hand function, followed by pain. Hand aesthetics was not a statistically 
significant predictor, but the authors concluded that patients may be reluctant to 
admit that they are seeking hand surgery primarily to improve the appearance of 
their hands. Improvement in hand appearance after MCP arthroplasty has been 
reported to correlate strongly with overall patient satisfaction (Bogoch & Judd, 
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2002; Mandl, Galvin, Bosch, George, Simmons, Axt, Fossel, & Katz, 2002). 
Rheumatoid hand deformities are often easily noticeable because the hands are not 
generally covered by any garment, thus the aesthetics needs to be evaluated as one 
of the indications for operative treatment. The eventual complications following 
surgery or the consequences of doing nothing, for example in a flail wrist with 
persistent synovitis, are weighed and discussed with the patient when considering 
surgical treatment of the rheumatoid hand (Trieb, 2008).  
 
2.3.2 General principles 
Surgical planning for patients with a systemic and chronic disease needs to include a 
holistic assessment of the patient. There is wide variation in the activity level of the 
RA patients. Patient needs in professional and social functions differ; someone 
prefers stability and strength of the hands, whereas another needs mobility of the 
hands. Rheumatoid involvement of the elbow or shoulder may significantly affect 
the overall success of the hand surgery. An eventual walking aid needs to be taken 
into account when a surgical method is chosen. The rheumatoid hand is assessed 
bilaterally in detail as an entity, and the surgical treatment is planned with an 
appreciation of the natural history of the disease and the pathophysiology of the 
deformities. One important principle is that even advanced deformities with 
architectural disorganization of multiple joints do not by themselves constitute an 
indication for surgery, because many patients maintain good hand function in spite 
of significant deformities. Progression of the disease and deformity in a specific 
joint should be taken into consideration when establishing an orthopaedic 
intervention protocol in order to achieve maximal patient benefit. Reconstructive 
operations should be performed before the development of severe loss of tissue and 
incurable disability (Souter, 1979; J. K. Stanley, 1998; Feldon et al., 2005; Simmen 
et al., 2008; Toyohara, Ishikawa, Abe, Nakazono, & Murasawa, 2009.) 
The concept “start with a winner” stated by the eminent rheumasurgeon William 
Souter, i.e. to perform the most beneficial and easily rehabilitated procedure first, is 
a valuable approach when surgical interventions are planned, particularly when 
multiple joints are damaged and symptomatic, as it facilitates patient’s acceptance 
and cooperation (Souter, 1979; O'Brien, 1996; Blomqvist et al., 2000). The 
deformities in the proximal joints are corrected before distal articulations, with the 
exception of urgent surgery performed for nerve compression and impending tendon 
rupture. The malalignment in the wrist has to be treated before MCP joint 
arthroplasties are performed (D. Stanley & Norris, 1988; J. K. Stanley, 1999; Burke, 
2011). The maximum extent of surgery in one session is tailored according to the 
general health of the patient and according to the duration of the tourniquet 
application. Stabilizing operations and mobilizing operations have to be performed 
in different sessions to facilitate postoperative rehabilitation (J. K. Stanley, 1992; 
Abboud et al., 2003; Little & Stern, 2007; Trieb, 2008.) 
A patient suffering from RA should also be carefully assessed preoperatively 
from the anaesthesiological point of view. The systemic extra-articular 
manifestations of RA and medication may cause kidney and/or liver failure. 
Occipito-atlanto-axial and subaxial cervical spine instability should be evaluated 
prior to anaesthesia to protect it during induction and the patient should be placed in 
21 
the proper surgical position. Cricoarytenoid and other laryngeal joints may be 
affected by RA. Dermal tissue is often atrophic and special care should be taken not 
to damage it (Abboud et al., 2003; Trieb, 2008) 
 
2.3.3 Methods 
The use of pure synovectomy or tenosynovectomy has decreased with the 
introduction of effective disease modifying therapies, but persistent symptomatic 
synovitis without articular surface destruction resistant to modern pharmacotherapy 
remains a valid indication for synovectomy operation. The synovectomy relieves 
pain and swelling, but there is no evidence available indicating that it reduces the 
antigen load or immune inflammation or alters the radiological disease progression 
in the longterm. Tenosynovectomy is used to prevent tendon ruptures and as a 
method to increase mobility, but the documentation on its prophylactic effects is 
weak (Simmen et al., 2008.) In the randomized clinical trial (RCT) performed by 
Nakamura and co-workers (2000) a radical multiple synovectomy was reported to 
have an anti-rheumatic effect by itself. Simultaneous synovectomies were 
performed on as many joints as possible in RA patients who did not respond to 
intensive conventional medical treatment, including combinations of methotrexate, 
sulphasalasine, bucillamine and corticosteroids. At a minimum follow-up of three 
years significantly more patients in the synovectomy treatment group were in 
clinical remission according to the ACR (American College of Rheumatology) 
criteria than in the group treated without surgery, but no differences were seen in the 
radiological deterioration. Synovectomy is always performed together with any 
surgical joint interventions in rheumatoid hand surgery as an additional procedure 
(Blomqvist et al., 2000; Simmen et al., 2008; Chung & Kotsis, 2010.) 
Soft-tissue balancing surgery is used to treat typical rheumatoid hand 
deformities; ulnar drift, shoemaker’s thumb, boutonniére deformity and swan-neck 
deformity when the joint is still radiologically well preserved. These deformities can 
be counteracted or corrected by various tendon transfer procedures, the release of 
tight ligaments or shortening of stretched ligaments (Blomqvist et al., 2000). 
Despite a trend towards improved functional outcomes reported in a systematic 
literature review, irrefutable evidence to support a long-term functional benefit of 
these procedures in RA patients is still lacking (Ghattas et al., 2005). Nervus 
medianus entrapment in the carpal canal is common in rheumatoid hand due to the 
synovitis of the flexor tendons, which increases the pressure in the canal. In the 
operation meticulous tenosynovectomy is performed in addition to the discision of 
the transverse ligament. Tendon ruptures, more common in extensors, are 
reconstructed by suturing the end of the ruptured tendon to an adjacent tendon, 
using tendon transfer procedures, or in multiple tendon ruptures using free tendon 
grafts. The treatment of tendon ruptures is usually combined with the resection of 
the ulnar head and with arthrodesis or arthroplasty surgery to eliminate the articular 
cause of the tendon rupture (Moran & Bishop, 2007; Simmen et al., 2008; Chung & 
Kotsis, 2010.)   
In the joints with cartilage or bone destruction either arthrodesis or arthroplasty 
are the surgical options. Arthrodesis is preferred in the joints in which stability is 
more important than mobility, and when painlessness is highly valued. The wrist, 
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DIP joints, MCP and IP joints of the thumb are typically fused in the rheumatoid 
hand (Blomqvist et al., 2000). Total wrist arthrodesis is a well-established, safe and 
reliable method for patients with advanced arthritic changes. In the early stages of 
RA, partial wrist arthrodesis preserves a significant range of motion but also enables 
stabilisation of the wrist (Trieb, 2008). The variable and often poor bone quality in 
RA should be taken into account when the fixation method is selected for 
arthrodesis surgery. Arthrodesis is sometimes the only possible treatment option in 
the most advanced destructions including notable malalignment with major bone 
defects (Blomqvist et al., 2000).  
In rheumatoid hand destroyed joints can be replaced with artificial joints 
(arthroplasty with endoprosthesis) or endogenous tissues (interposition 
arthroplasty), such as tendon, ligaments or connective tissue. In MCP joints one-
piece silicone implant arthroplasty has been widely used and is well documented in 
RA patients, but deterioration of the results initially achieved over time is 
commonly reported (Goldfarb & Dovan, 2006). Problems associated with 
rheumatoid hand arthroplasties are the accurate placement of the physiologic centre 
of rotation of a joint, fixation of the prosthesis to bone and imbalance in the soft 
tissue with a tendency for malalignment in the joint (Blomqvist et al., 2000). 
Prosthetic development in small joint arthroplasties is an ongoing process, and 
issues such as biocompatibility, ease of implantation and stability must be taken into 
consideration (Linscheid, 2000). Long-term problems requiring revision surgery 
after a primary wrist arthroplasty are still common (Ghattas et al., 2005; Trieb, 
2008). In the review article by Cavaliere and Chung (2008) the authors concluded 
that hand function after wrist arthroplasty may not be significantly better than after 
an arthrodesis, and that current evidence does not support the widespread 
implementation of wrist arthroplasty in RA. In the PIP joints, the inherent lack of 
ligament support as well as tendon imbalances in RA make the arthroplasty 
procedure an unsure option (Chung & Kotsis, 2010).   
The reliable evaluation of new surgical methods requires extensive clinical trials 
involving large numbers of patients, and the evaluation of these new methods in RA 
patients (as distinguished from the much larger and homogenous osteoarthritis 
patient population) is an ongoing challenge (Simmen et al., 2008). However, 
patients should be informed of the options available in surgical treatment by 
surgeons specialised in rheumasurgery (Chung & Kotsis, 2010).  
 
 
1975 to 1990 
3. Radiocarpal partial wrist arthrodesis in 
rheumatoid hand surgery 
3.1 Pathophysiological and kinematic basis 
RA of the wrist typically begins in the radiocarpal joint, preserving the midcarpal 
joint (J. K. Stanley & Boot, 1989). The radiocarpal joint is anatomically less stable 
than the midcarpal joint and more susceptible to instability caused by the disease 
process (Ishikawa et al., 2005). It was reported that there were no further 
subluxations and that the functional range of motion was maintained after a 
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spontaneous radiolunate fusion in RA. This gave rise to the idea of a new surgical 
method to stabilise the rheumatoid wrist (Linscheid & Dobyns, 1971; Chamay, 
Della Santa, & Vilaseca, 1983). The instability problems often occurring in the 
carpus after the commonly used distal ulnar head resection likewise stimulated 
interest in partial wrist arhtrodesis operation. Chamay was the first to report a 
radiolunate fusion procedure for the rheumatoid wrist (Chamay et al., 1983). 
Compared to the most frequently used operation in rheumatoid wrist surgery, total 
arthrodesis, the range of motion preserved after a partial radiocarpal arthrodesis is 
an obvious advantage.   
The functional motion in the wrist necessary for most ADL is from 10° of flexion 
to 35° of extension (Brumfield & Champoux, 1984; Palmer, Werner, Murphy, & 
Glisson, 1985). The combination of radial deviation and extension with ulnar 
deviation and flexion (the dart thrower’s motion) has been described as the 
dominant motion arc for many occupational activities (Li, Kuxhaus, Fisk, & 
Christophel, 2005; Rohde, Crisco, & Wolfe, 2010). Relevant in this context, the 
scaphoid and lunate motion is minimal throughout the dart thrower’s motion arc 
(Werner, Green, Short, & Masaoka, 2004). Yayama et al. (2007) reported that 
disturbed coupling of flexion-extension and radio-ulnar deviation results in 
difficulties in the cooperative movements and have a great influence on daily 
activities in the RA wrist joint (Yayama, Kobayashi, Kokubo, Inukai, Mizukami, 
Kubota, Ishikawa, Baba, & Minami, 2007). In unstable rheumatoid wrists the 
congruity in the midcarpal joint is generally well preserved and the contribution of 
the midcarpal motion has been shown to be 2/3 relative to the total wrist motion 
(Arimitsu et al., 2007; Arimitsu, Sugamoto, Hashimoto, Murase, Yoshikawa, & 
Moritomo, 2008).  
 
3.2 Indications 
Partial radiocarpal arthrodesis is indicated in the rheumatoid wrist with pain and/or 
chronic synovitis in spite of conservative treatment. The midcarpal joint has to be 
relatively well preserved (Chamay & Della Santa, 1991; Ishikawa, Hanyu, Saito, & 
Takahashi, 1992). In RA radiocarpal arthrodesis has been used in unstable wrist 
destruction with an ulnar translocation and/or a palmar subluxation of the carpus. 
Theoretically, surgical stabilisation and correction of the malalignment in the carpus 
may also prevent or delay the development of the ulnar drift of the fingers (Doets & 
Raven, 1999; Herren & Ishikawa, 2005).  
 
3.3 Surgical technique 
Radiocarpal arthrodesis and radioulnar arthrodesis are the most commonly used 
methods of limited arthrodeses in rheumatoid wrist due to early arthritic destruction 
of both radiocarpal and radioulnar joints, which is combined with a tendency to 
develop instability in the radiocarpal joint (J. K. Stanley & Boot, 1989; Arimitsu et 
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al., 2008). The other partial arthrodesis techniques described in the literature are 
rarely used in the rheumatoid hand. The isolated radiolunate (RL) arthrodesis 
enables the stabilisation and repositioning of the carpus, but if there is an adjoining 
destruction of the radioscaphoid joint, the scaphoid is added to the fusion 
(radioscapholunate or RSL arthrodesis) (Ishikawa et al., 1992; Herren & Ishikawa, 
2005).  
A dorsal straight skin incision is the most widely used surgical approach (J. K. 
Stanley & Boot, 1989; Chamay & Della Santa, 1991; Herren & Ishikawa, 2005), but 
an oblique exposure has also been described (Ishikawa et al., 1992). The extensor 
retinaculum is opened longitudinally at the sixth compartment and raised as a 
radially-based flap, opening the extensor compartments. The synovectomy of the 
extensor tendons is performed routinely, and usually the terminal branch of the 
posterior interosseus nerve is resected. The ulnar head resection is typically 
combined with radiocarpal arthrodesis.  
Preparation of the surfaces of the lunate fossa of the radius and proximal lunate 
in the RL arthrodesis, and also of the surfaces of the scaphoid fossa of the radius and 
proximal scaphoid bone in the RSL arthrodesis is done to the level of the 
subchondral cancellous bone. This enables the consolidation of the arthrodesis. The 
aim is to reponate the lunate to a neutral and as physiological position as possible 
(Linscheid & Dobyns, 1985; J. K. Stanley & Boot, 1989; Chamay & Della Santa, 
1991; Herren & Ishikawa, 2005; Ishikawa et al., 2005). In advanced cases, with 
fixed carpal collapse, Borisch and Haussmann (2002) reported that anatomical 
repositioning of the lunate leads to midcarpal dislocation and precipitates a 
secondary osteoarthritis, however neutral positioning of bones in the dorsovolar 
dimension was recommended. Bone grafting of the resected ulnar head is often 
needed for a good repositioning and to fill the gap between the lunate and radius 
and, in RSL arthrodesis, also between the scaphoid and radius. A slight distraction 
of the lunate seems to enable more free rotation to the scaphoid and slightly better 
postoperative ROM (Linscheid & Dobyns, 1985; Masuko et al., 2009). The 
reduction is temporarily maintained with K-wires and repositioning is checked using 
fluoroscopy. Staples, screws, miniplates, K-wires or sliding graft of the radius can 
be used for final fixation. Gaulke and co-workers (2010) reported a high rate of 
radiological complications of staple fixation in the RL fusion. The capsule and 
retinaculum are closed to stabilise the ulnar stump. The retinaculum is divided and 
one part is sutured above the extensors to prevent a bowstring phenomenon.  
A short arm cast or splint is applied for 6-8 weeks. After signs of consolidation in 
the radiographies, mobilisation of the wrist can be started. Usually mobilisation is 
started six weeks after the operation, but has been started already 2 weeks 
postoperatively when plate fixation was used (J. K. Stanley & Boot, 1989) or only 
after 12 weeks when fixation with K-wire was used (Linscheid & Dobyns, 1985).  
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3.4 Outcome 
3.4.1 Clinical outcome 
Pain alleviation is successfully achieved with radiocarpal arthrodesis. Some pain 
alleviation may result from simultaneous synovectomy, ulnar head resection and 
resection of the posterior interosseus nerve, which are typically combined with 
radiocarpal arthrodesis (Borisch & Haussmann, 2002; Masuko et al., 2009). The 
progression of arthritis, secondary osteoarthritis in the midcarpal joint and hardware 
displacement are the main reasons for pain after surgery. Subjective satisfaction is 
excellent or good after radiocarpal arthrodesis from 74% to 87% of cases (Linscheid 
& Dobyns, 1985; J. K. Stanley & Boot, 1989; Chamay & Della Santa, 1991; Gaulke 
et al., 2010).  
The ROM of the wrist maintained after radiocarpal arthrodesis varies widely 
between studies. A decrease of wrist motion in all directions, but significantly only 
for wrist flexion, has been reported in many studies. In contrast to other publications 
Doets and Raven (1999) reported a postoperative increase in mobility in all 
directions with the exception of wrist flexion. The extension-flexion motion ranges 
from 36° to 70° after radiocarpal arthrodesis, representing 56 – 93% of the 
preoperative arc of motion. ROM in the great majority of operated cases is within a 
satisfactory and functional range (Masuko et al., 2009). In the study by Doets and 
Raven (1999) the postoperative extension-flexion ROM was 74°, being two degrees 
more than preoperatively. After RL fusion the range of motion is wider and better 
preserved than after RSL fusion (Meyerdierks, Mosher, & Werner, 1987; Ishikawa 
et al., 2005). Borisch and Haussmann (2002) reported that the reduction in the wrist 
movement was not dependent on the preoperative mobility of the wrist, but the 
postoperative mobility was lower in Larsen Grade IV wrists than in Larsen grade III 
wrists. The mobility of RL arthrodesis has been reported to be better in RA than in 
trauma patients or in cadaver studies, probably due to the laxity of the ligamentous 
structures in RA (Watson, Goodman, & Johnson, 1981; Meyerdierks et al., 1987; 
Chamay & Della Santa, 1991). Supination and pronation of the forearm increase in 
most cases because of the resection of the distal ulna.  
Grip power improves modestly after radiocarpal arthrodesis (Linscheid & 
Dobyns, 1985; J. K. Stanley & Boot, 1989; Chamay & Della Santa, 1991; Ishikawa 
et al., 1992; Ishikawa et al., 2005; Masuko et al., 2009) but alteration of hand 
function has been reported only in two publications, in which the evaluations were 
performed using questionnaires. Amelioration was observed in 60 – 67% of patients 
(J. K. Stanley & Boot, 1989; Gaulke et al., 2010). 
Some wrists become totally fused after radiocarpal arthrodesis. In the study by 
Ishikawa et al. (2005) 12% of wrists had evolved into total fusion at the mean 
follow-up of three years. If further spontaneous arthrodesis occurs, the wrist remains 
in a functional position (Linscheid & Dobyns, 1985; Ishikawa et al., 1992). Surgical 
conversion to total arthrodesis was performed in 8-9% after radiocarpal arthrodesis 
due to progressive midcarpal destruction or recurrence of painful synovitis (Doets & 
Raven, 1999; Borisch & Haussmann, 2002).  
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Table 1.   Summary of studies evaluating outcome of partial radiocarpal wrist arthrodesis in rheumatoid hand surgery 
 
Wrists Follow-up ROM Grip power Study Type 1 
(n) (months) 
Pain 2 Subjective 
satisfaction 2 post (pre) 3 post (pre) 
Midcarpal 
destruction 4 
Total fusion 
reoperation (n) 
Stanley and Boot 
(1989)  
pros 16 24 13 painless 12 excellent or 
good 
52 (56) 3.2 (2.5) lbs 12 (75%)  
Chamay and Della 
Santa (1991) 
retro 21 49 13 painless 11 entirely 
satisfied 
69 (-)   1 
Ishikawa et al. 
(1992) 
pros 25 36 21 painless  36 (64) 114 (80) 
mmHg 
12 (48%)  
Doets and Raven 
(1999) 
pros 39 60 VAS 8.3  VAS 9  74 (72)   4 
Borisch and 
Haussmann (2002) 
retro 91 60 48 painless 88 same 
operation again 
46 (74)  66 (72%) 6 
Ishikawa et al. 
(2005) 
retro 25 156 22 painless  35 (54) 141 (100) 
mmHg 
9 (36%) 0 
Gaulke et al. (2009) pros 20 19 14 painless 18 very good or 
good 
43 (108) 0.28 (0.17) bar   
Masuko et al. (2009) retro 12 69 12 none or 
mild 
12 excellent or 
goog 
68 (88) 17.8 (12.0) kg 2 (17%) 0 
Gaulke et al. (2010) retro 22 60 13 painless 18 excelleny or 
good 
70 (-)  2  
1
  prospective or retrospective study 
2
  VAS 10 indicates no pain or fully satisfied  
3
  range of motion, post = at follow-up, pre = preoperatively 
4
  number and proportion of the joints in which some midcarpal changes were evaluated at follow-up compared to preoperative x-rays 
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The most common complication after radiocarpal arthrodesis is primary intra-
articular displacement of the fixation material (Linscheid & Dobyns, 1985; Ishikawa 
et al., 2005). In the study by Borisch and Haussmann (2002) with a larger patient 
population malposition of fixation material was observed in 4% of cases. 
Occurrences as high as 31% and 41% of malposition of fixation material have been 
reported, and the use of intraoperative radiologic control has been recommended 
(Doets & Raven, 1999) while some surgeons have changed from staples to 
miniplates (Gaulke et al., 2010).   
 
3.4.2 Radiological outcome 
Radiocarpal arthrodesis prevents dislocation of an unstable rheumatoid wrist (Della 
Santa & Chamay, 1995), and non-union rates are low, on average 4 - 6% (Linscheid 
& Dobyns, 1985; J. K. Stanley & Boot, 1989; Chamay & Della Santa, 1991; 
Ishikawa et al., 1992; Borisch & Haussmann, 2002). Redislocation and bony fusion 
in an undesirable position are more frequent concerns (Gaulke et al., 2010). 
Particular index measurements are made from radiographs to evaluate the position 
of the carpus. Carpal height improves after surgery because of the repositioning of 
the carpal bones and bone grafting, but reverts near to the preoperative level over 
time (Della Santa & Chamay, 1995; Ishikawa et al., 2005).  The deterioration in 
carpal height has been found to be similar after RL arthrodesis as in non-operated 
contralateral wrists, which may reflect the effects of the rheumatoid disease itself 
(Della Santa & Chamay, 1995). Ulnar translocation often improves after radiocarpal 
arthrodesis (Della Santa & Chamay, 1995), and has been reported to remain 
unchanged in 10-year follow-up (Linscheid & Dobyns, 1985; Doets & Raven, 1999; 
Borisch & Haussmann, 2002; Ishikawa et al., 2005). However, in the study by Doets 
and Raven (1999) slow but significant deterioration in ulnar translocation was 
reported after the RL arthrodesis.  
The midcarpal joint changes after radiocarpal arthrodesis have been reported to 
develop in as many as half of the cases in studies with over five-year follow-up. In 
the study by Ishikawa et al. (2005) widening of the lunocapitate joint space (>2 
mm), was observed in 16% of wrists, and narrowing (<1 mm) in 20% at mean 13-
year follow-up. In 12% of cases the wrist joint was totally fused. However, in 64% 
of the wrists the midcarpal joint was well preserved. Borisch and Haussmann (2002) 
reported arthritic changes in 37% of wrists, and osteoarthritic changes in 35% of 
wrists at mean 60-month follow-up. In their study an exceptionally high proportion 
(44%) of the wrists was further destroyed (Larsen IV), and they observed lesser 
destruction in the midcarpal joint in early stage disease. Most patients remain 
asymptomatic despite midcarpal deterioration, probably because of a better intrinsic 
stability in the midcarpal than in the radiocarpal joint (J. K. Stanley & Boot, 1989; 
Ishikawa et al., 1992; Doets & Raven, 1999).   
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4. MCP arthroplasty in rheumatoid hand 
surgery 
4.1 Indications 
The indication for MCP joint arthroplasty in RA is radiographic joint destruction 
accompanied by pain or functional impairment. The improvement in the appearance 
of the hand is also highly valued by patients (Mandl et al., 2002; Massy-Westropp, 
Massy-Westropp, Rankin, & Krishnan, 2003; Chung, Kotsis, & Kim, 2004; 
Goldfarb & Dovan, 2006). A typical functional impairment arises from palmar 
subluxation and ulnar deviation of the MCP joints causing loss of extension and 
difficulties to grasp, especially large objects. Pain in the MCP joints may itself 
inhibit hand function. Joint replacement surgery in MCP joints is used in advanced 
stages, and in many patients all four MCP joints are replaced simultaneously. Some 
patients adapt well to major deformities, at least partially because of the slow 
progression, and if the function is sufficient for the patient’s needs, surgery is not 
indicated. Progressive bone destruction and the feasibility of soft tissue balancing 
should, however, be considered in the timing of MCP surgery (Goldfarb & Dovan, 
2006).  
 
4.2 Methods 
4.2.1 Development of the implants 
Reconstructive surgery in rheumatoid MCP joints was started with simple joint 
resections (Ruther, Verhestraeten, Fink, & Tillmann, 1995). Many autoarthroplasty 
techniques using the patient’s own tissue as an interposition material were described 
before implant artrhroplasty was developed. In Vainio resection arthroplasty an 
extensor tendon is interposed and fixed into the volar plate (Vainio et al., 1967). 
Tupper’s method uses a volar plate as an interposition (Tupper, 1989). Simple joint 
resection surgery and soft tissue interposition arthroplasties have been reported to 
cause problems due to limited motion, lack of stability and recurrent deformity, and 
nowadays the use of these techniques is relatively rare (Ruther et al., 1995; Gotze & 
Jensen, 2000).  
The development of hand joint implants has not advanced as favourably as the 
development of hip and knee joint prostheses. The small sizes of the joints, their 
participation in delicate kinetic chains and their complex soft tissue investments in 
relationships to adjacent rays are challenges for joint replacement surgery in the 
hand. Inflammatory attenuation of supporting soft tissue and osteoporotic bone with 
varying degrees of bone erosions impose additional needs for proper implant 
stability and fixation in rheumatoid hands, and RA is by far the most important 
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indication for MCP joint replacement (Linscheid, 2000; W. L. Parker, Rizzo, 
Moran, Hormel, & Beckenbaugh, 2007). The aims for the development of MCP 
joint implants are restoration of a functional range of motion, adequate stability, 
biologic compatibility, adequate material wear and strength characteristics, 
provision for easy implantation and allowance for soft tissue reconstruction. A 
proper implant also enables revision surgery without major bone loss and tissue 
damage (Linscheid, 2000). 
Many prosthetic designs have been introduced into MCP joint replacement over 
the last 50 years. These can be grouped into one of three basic designs: the hinged 
prosthesis, the flexible prosthesis, and the third-generation resurfacing prosthesis 
(Merolli, 2009). The earliest implants were hinged metallic prostheses, which had a 
high failure rate and are no longer in use. Polyethylene was introduced as a bearing 
material to reduce friction, and it often replaced at least one stem. Cemented 
implants were implemented to ensure implant fixation, but due to high failure rates 
and laborious operating technique they were withdrawn from the market (Wilson & 
Carlblom, 1989). Flexible prostheses, which were manufactured of silicone rubber 
alone or combined with Dacron, were introduced in the 1960’s.  The one-piece 
implant of silicone elastomer developed by A.B. Swanson in 1964 is still the gold 
standard in MCP joint replacement surgery in RA patients. Development work on 
prostheses aiming to restore the normal joint anatomy has been continued.  Designs 
which aim to reproduce the anatomical centre of rotation and to fit better into the 
phalangeal and metacarpal bone canals have been introduced. The third-generation 
resurfacing prostheses comprise surface replacement prostheses and devices that 
represent a hybrid of hinged and flexible prostheses (Joyce, 2004; W. Parker, 
Moran, Hormel, Rizzo, & Beckenbaugh, 2006). Numerous third-generation devices 
have been produced and implanted but now appear to be no longer in use; implant 
fractures and dislocations, bone loss, recurrence of ulnar drift and decreasing hand 
function over time have been reported as consequences of their use. Implantation 
techniques have also been found too demanding to reproduce consistently good 
results (Beevers & Seedhom, 1995; Cook, Beckenbaugh, Redondo, Popich, 
Klawitter, & Linscheid, 1999; Linscheid, 2000). 
 
 
Figure 4.  History and development of MCP joint prostheses. (A) hinged implants, (B) 
flexible designs and (C) resurfacing prosthesis 
 
 
30 
 
The pyrolytic carbon implant is the best documented surface replacement 
prosthesis for the MCP joints. Pyrolytic carbon coating is wear-resistant and 
chemically stable, and has an elastic modulus similar to that of cortical bone. The 
elastic component dampens stresses at the bone prosthetic interface and enhances 
biological fixation (Cook et al., 1999). The two-piece non-constrained implant 
allows for preservation of the collateral ligaments and requires only minimal joint 
resection, but the disadvantages are the risk of subluxation and dislocation, 
especially when the surrounding soft tissues are loose or damaged. A non-
constrained prosthesis requires a very precise placement of the device and adequate 
sizing to ensure a proper soft-tissue balancing (Goldfarb & Dovan, 2006; W. Parker 
et al., 2006). A long-term study reporting minimum 10-year follow-up shows good 
results, with 5- and 10-year survival rates at 82% and 81% respectively; however, 
patients treated in this series had only minor preoperative deformities, subluxations 
or dislocations of the MCP joints (Cook et al., 1999). Parker et al. (2007) reported 
increased radiolucent seam around the pyrolytic carbon implants in 95% of RA 
cases with a longer than 1-year follow-up.  
Designs of the MCP prosthesis matching the anatomy of the natural joint more 
closely have been produced and tried but have not yet demonstrated long-term 
clinical success in cases of severe RA, although slightly better results have been 
achieved in OA. RA of the MCP joint poses a severe and ongoing challenge to any 
prosthesis implanted (Joyce, 2004; Goldfarb & Dovan, 2006).  
 
4.2.2  Silicone implant arthroplasty 
For several decades the one-piece silicone implant designed by Swanson has 
remained the joint replacement of choice for the MCP joints. According to the data 
in the Norwegian Arthroplasty Register 1,400 Swanson prostheses were implanted 
out of a total of 2,154 MCP prostheses over the period 1994 to 2002 (Joyce, 2004). 
In the USA the Swanson implant has been reported to have about 75% of the market 
for implants for use in the RA hand (Chung et al., 2004). Later developments in the 
Swanson prosthesis have been alterations in the composition of the silicone polymer 
to provide better resistance to tear propagation and metal grommets at the stem-hub 
junction to protect the implant from abrasion and prevent erosions at the bone ends. 
The high-performance (HP) elastomer was developed in 1974, and since 1986 
Swanson prosteheses have been manufactured of HP-100 silicone elastomer 
(Swanson, Poitevin, de Groot Swanson, & Kearney, 1986; Linscheid, 2000; Joyce, 
2004). The change of silicone material has had a positive effect on fracture rates, but 
the benefit of the grommets has not been clinically confirmed and they are not 
widely used (Beevers & Seedhom, 1995; Schmidt, Willburger, Ossowski, & 
Miehlke, 1999; Joyce, 2004). 
The Swanson prosthesis has a spacer located in the joint level with two adjoining 
stems attached to it and to be implanted to the proximal and distal intramedullar 
canals. A wide, convex dorsal arch in the hinge area holds the bone ends apart and 
favours motion in the flexion plane.  
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Figure 5.  Swanson silicone MCP joint prosthesis ap and lateral view 
 
 
 
The stems act like pistons within the bone to permit more motion, and they also help 
to maintain alignment during the encapsulation process in the early phase after 
implantation. The development of a proper capsule is extremely important for the 
outcome, especially for the stability of the joint (Swanson, 1997). The formation of 
a functional and stable fibrous capsule requires the initiation of early motion using 
sophisticated and lengthy postoperative orthoses (Egloff, 1998; Goldfarb & Dovan, 
2006).   
The Swanson prosthesis has been reported to flex at the hinge after a flexion 
angle of 45° has been passed, but below that the implant flexes at the stem-hinge 
interface (Beevers & Seedhom, 1995). Modifications of the Swanson implant have 
been developed to improve the biomechanics and to reduce force transfer into the 
implant (Joyce, 2004; Escott, Ronald, Judd, & Bogoch, 2010). In the Sutter 
prosthesis introduced in 1987 (nowadays called Avanta) a similar silicone polymer 
(Silastic) is used and the stems have the same shape, but the axis of rotation has 
been placed more palmarly to facilitate extension by increasing the extensor 
moment arm. The hinge is enlarged and between the stems and hinge area is a sharp 
angled border to reduce the risk of palmar bony impingement (Bass, Stern, & 
Nairus, 1996). The NeuFlex prosthesis introduced in 1998 has a preflexed 30° angle 
in the hinge and the centre of the rotation is located palmarly with respect to the 
longitudinal axis of the implant. The idea of the design is to simulate the relaxed 
position of the hand, to offer better ROM by increasing flexion and to reduce 
pistoning of the stems (Delaney, Trail, & Nuttall, 2005). All silicone implants have 
a tendency to fracture in or near the centrepiece of the hinge element, and they have 
been considered unsuitable for younger patients who apply greater forces and place 
higher demands on their implants (Linscheid, 2000; Joyce, 2004). Expectancy of 
outcome and demands on loading of the MCP joint implants have increased among 
RA patients with more active lifestyle as a consequence of improved medication, 
and the search for improved MCP implants will continue (Joyce, 2004; Goldfarb & 
Dovan, 2006). 
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4.2.3 Soft tissue balancing  
In the RA hand there are often disturbances throughout the entire kinetic chain from 
the wrist to the distal interphalangeal joint. This, combined with the suboptimal 
properties of the available MCP implants, necessitates a careful approach to soft 
tissue reconstruction in MCP joint replacement surgery. Release of a contracted 
ulnar collateral ligament and volar capsule are routinely performed and many also 
release ulnar intrinsic muscles, including the abductor digiti minimi. Some surgeons 
prefer to save the ulnar intrinsic muscle of the index finger on order to preserve the 
function of the first palmar interosseus muscle in pinch grip (Stirrat, 1996; Abboud 
et al., 2003). After the bone resection and the release of the contracted soft tissues, it 
should be possible to displace the proximal phalanx onto the dorsum of the 
metacarpal (Wilson & Carlblom, 1989; Goldfarb & Dovan, 2006).  
The radial collateral ligament may be tightened by duplicating it or by proximal 
re-attachment through a drill hole to the metacarpal bone. Many surgeons perform 
this for all joints if needed, but some prefer to do it only in the index finger 
(Delaney et al., 2005; Moller, Sollerman, Geijer, Kopylov, & Tagil, 2005; 
Pettersson, Wagnsjo, & Hulin, 2006). If the collateral ligament is severely 
attenuated, a radial reconstruction can be done with the volar capsule and half of the 
volar plate, which are attached to the origin of the collateral ligament (Stirrat, 1996; 
Sunil & Kleinert, 2006). In cases with major erosions on the phalangeal bones the 
distal insertion of the radial collateral ligament has to be checked and reconstruction 
is performed if needed (Wilson & Carlblom, 1989). Reinsertion of both collateral 
ligaments to the metacarpal bone has been described with surface replacement 
prostheses (Rittmeister, Porsch, Starker, & Kerschbaumer, 1999). Crossed intrinsic 
transfer (CIT) has been used in MCP arthroplasty surgery to enhance and maintain 
the correction of the ulnar drift. In the retrospective study by Clark and co-workers 
(2001) the CIT group had less ulnar drift compared to the non-CIT group at a mean 
follow-up of 50 months, and CIT was described as one of the factors which 
improved silastic MCP joint arthroplasty survival in a retrospective radiological 
study with 17-year follow-up (Trail et al., 2004). In the randomised comparative 
study by Pereira et al. (2001) it was concluded that CIT does not significantly affect 
the outcome of silicone implant arthroplasty of the MCP joints in rheumatoid 
patients. In the majority of publications concerning silicone MCP arthroplasty in RA 
CIT was performed on only a few patients with severe deformities. The 
reconstruction of the extensor mechanism by reefing the radial sagittal band and 
centralising the extensor tendon is essential and routinely done for soft tissue 
balancing. There is a paucity of research data proving the value of soft tissue 
reconstruction techniques, and in widely varying perioperative situations the 
surgeon’s decision is based on clinical experience.   
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4.3 Results of silicone implant arthroplasty 
4.3.1 Outcome evaluation 
Because of the systemic and progressive nature of RA it is difficult to assess the 
outcome of a particular surgical procedure in rheumatoid hands, especially in the 
longterm (Goldfarb & Stern, 2003). Confounding factors influencing the outcome 
include impairment of adjacent joints, condition of the soft tissues, medication and 
variation in disease severity between patients and variation in disease activity of an 
individual patient (Nalebuff, 1984; Ruther et al., 1995; Synnott, Mullett, Faull, & 
Kelly, 2000). The discrepancy between fair clinical results and good subjective 
results after MCP arthroplasty has been reported in many studies (Schmidt, 
Willburger, Miehlke, & Witt, 1999; Synnott et al., 2000; Bogoch & Judd, 2002; 
Chung et al., 2004). Mandl and co-workers (2002) investigated which outcomes 
correlate most strongly with patient satisfaction in a retrospective study evaluating 
26 RA patients with 160 MCP silastic implants at mean 5.5 years after surgery. This 
study found that postoperative patient satisfaction correlated most strongly with the 
appearance of the hand. Pain and to a lesser degree, subjective assessment of 
function, also correlated with satisfaction. Objective measures such as strength and 
range of motion correlated only minimally with patient satisfaction (Mandl et al., 
2002). The patient-centred determinants of outcome in rheumatoid hand surgery 
have been emphasised in the recent literature (Mandl et al., 2002; Chung et al., 
2004; Goldfarb & Dovan, 2006; W. L. Parker et al., 2007). However, the 
determination of the subjective outcome of surgical treatment of patients with RA 
has confounding factors similar to those already mentioned above for objective 
outcome evaluation.  The effect of overall health status on specific outcomes should 
also be considered (Goldfarb & Stern, 2003). 
 
 
4.3.2 Clinical results 
Before year 2005 most publications concerning silicone MCP joint arthroplasty in 
RA were retrospective studies; only one randomised study comparing the Swanson 
implant with the Sutter implant (McArthur & Milner, 1998) and a few prospective 
studies of Swanson arthroplasty (Kirschenbaum, Schneider, Adams, & Cody, 1993; 
Hansraj et al., 1997; Schmidt, Willburger et al., 1999) were published. RCTs 
comparing Avanta and NeuFlex to the Swanson prosthesis and Swanson 
arthroplasty with medical treatment have been published in the past few years 
(Delaney et al., 2005; Moller et al., 2005; T. Parkkila et al., 2005; Tagil, Geijer, 
Malcus, & Kopylov, 2009). Patient satisfaction and subjective results were basically 
good, but clinical outcome assessed by quantitative measurements was only fair.  
In the clinical outcome of Avanta or NeuFlex compared with the Swanson 
prosthesis no significant differences were observed. In the study by McArthur and 
Milner (1998) improvement in grip strength and ROM was better in the Swanson 
group than in the Avanta group, but this finding has not been confirmed in other 
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studies (Moller et al., 2005; T. Parkkila et al., 2005; Tagil et al., 2009). The fracture 
rate was higher with Avanta prosthesis (36%) compared to the Swanson prosthesis 
(11%) in the study by Tägil et al. (2009) in which 18 patients with 72 implants were 
followed-up for 60 months. On the other hand in the study comparing 89 Swanson 
implants to 126 Avanta (Sutter) implants no significant difference was observed in 
the fracture rate 58 months after surgery (T. J. Parkkila et al., 2006), (Table 3). In 
studies comparing NeuFlex implants with Swanson implants slightly better flexion 
measurements were reported, but no significant differences were observed in ROM 
(Delaney et al., 2005; Escott et al., 2010). The subjective evaluation of function 
improvement according to the Michigan Hand Outcome Questionnaire (MHQ) was 
better in the Swanson than in the NeuFlex group (Escott et al., 2010).  
The active ROM after silicone MCP arthroplasty varies from 27° to 56°, and it is 
either slightly improved from the preoperative ROM or more often sustained at the 
preoperative level. Deterioration of ROM has also been reported, mainly due to a 
distinct decrease in the flexion arc (Hansraj et al., 1997; Schmidt, Willburger et al., 
1999; T. Parkkila et al., 2005.) The extension lag is systematically improved and 
postoperative extension lags ranging from 7° to 31° have been reported, whereas a 
mild deterioration in flexion arc is a typical finding (Table 2). Only in the study by 
Pettersson and co-workers (2006)comparing NeuFlex and Avanta prostheses was 
postoperative flexion higher than the preoperative flexion, and an exceptionally 
good flexion arc (83° and 82°) was reported for both groups. Silicone MCP joint 
arthroplasty does not restore normal motion in the MCP joints, but because the arc 
of motion shifts toward more extension, it improves hand function by allowing 
patients to hold larger objects (Chung, Kowalski, Myra Kim, & Kazmers, 2000). 
The effect of MCP arthroplasty on palmar subluxation has not been separately 
described in the literature but the extension lag reflects to some extent the palmar 
dislocation. The correction of the ulnar deviation is achieved systematically, and 
postoperative deviation varies from 4° to 23° (Table 2).  Slight improvements in 
grip strength measurements have not been statistically significant in most studies 
(Schmidt, Willburger et al., 1999; Chung et al., 2004; Delaney et al., 2005; Moller et 
al., 2005; T. Parkkila et al., 2005; Tagil et al., 2009)), but significant improvement 
in grip strength has also been reported (Pereira & Belcher, 2001; Pettersson et al., 
2006). The small patient groups, 18 – 45 patients, divided into two study groups in 
these controlled trials, may have influenced the outcome of these studies. In the 
RCT study by Escott et al. (2010) grip strength improved significantly, when the 
larger Jamar grip position 4 (2-7/8”) was used in both the Swanson and NeuFlex 
groups, but not when the two smaller positions 2 or 3 were used, which on the other 
hand is the grip position which has been used in many earlier studies. 
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Table 2.   Summary of selection of studies evaluating clinical outcome of silicone MCP artrhoplasty in rheumatoid hand 
 
N Follow-up Study Implant  
Patients Joints (months) 
Extension 
deficit 
Flexion ROM 
change 
Ulnar 
deviation  
Scores 
Vahvanen and 
Viljakka (1986)  
Swanson 32 107 45 7 41  9,11,12,15*  
Gellman et al. (1997) Swanson 264 901 96 10 60 + 15  
Hansraj et al. (1997) Swanson 71 170 63 28 55 -   
Rothwell et al. (1997) Swanson 21 92 38 16 51  4 UEFT + 
Schmidt et al. (1999) Swanson 28 102 102 10 45 - 10  
Synnott et al. (2000) Swanson 25 98 30 20 60  14 Jebsen-Taylor + 
Clark et al. (2001) Swanson 
CIT/no1 
28/45 112/180 54/46 15/14 52/52  6/14  
Goldfarb and Stern 
(2003) 
Swanson 36 208 168 23 59 0 16  
Delaney et al. (2005) Swanson/ 
NeuFlex 
10/12 37/40 24 19/16 59/72 +/+ 7/9 SODA +/+ 
Möller et al. (2005) Swanson/ 
Avanta 
30 120 24 16/19 47/61 0 / + 10/13 Sollerman 0/0 
Parkkila et al. (2005) Swanson/ 
Avanta 
45 75/99 58 12/16 54/63 -/- 5/7  
Pettersson et al. 
(2006) 
NeuFlex/ 
Avanta 
40 78/78 12 20/21 83/82 +/+  COPM +/+ 
Tägil et al. (2009) Swanson/ 
Avanta 
18 72 60 14/17 41/53 0/0 7/12 Sollerman 0/0 
Chung et al. (2009) Swanson/ no 
operation2 
45/72  12 29/49 60/83 +/0 13/34 MHQ +/0, AIMS2 0/0 
Chung et al. (2009) Swanson 
less/more 
severe3 
70  12 26/31 56/63 0/+ 9/18 MHQ +/+, AIMS2 0/0,  
Escott et al. (2010) Swanson/ 
NeuFlex 
33 160 12 14/21 56/75 +/+ 7/10 Sollerman +/+, MHQ +/+ 
+ = improvement from preoperative, - = deterioration , 0 = no change compared to preoperative  
*   by each finger  
1 
 comparison between operation technique with crossed intrinsic transfer or without  
2 
 comparison between Swanson arthroplasty and conservative treatment  
3 
 comparison between less severe and more severe MCP destruction 
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Patient-centred outcome evaluation instruments, such as the MHQ, have been 
used in recent studies, and they have shown an improvement in all subscores 
describing patient’s hand-specific function, ADL, pain, work performance, 
aesthetics and satisfaction (Chung et al., 2004; Chung, Burns et al., 2009; Escott et 
al., 2010). Pain relief was achieved in 71-100% of patients, but only 28-54% of 
patients were totally pain free (Vahvanen & Viljakka, 1986; Bass et al., 1996; 
Gellman, Stetson, Brumfield, Costigan, & Kuschner, 1997; Hansraj et al., 1997; 
Goldfarb & Stern, 2003). However, in the study by Pettersson et al. (2006) no 
significant difference was found in pain (evaluated by VAS) postoperatively 
compared with preoperative values. Improvement in the appearance of the hand is 
highly appreciated by patients, and is commonly achieved after MCP silicone 
arthroplasty (Vahvanen & Viljakka, 1986; Kirschenbaum et al., 1993; Bass et al., 
1996; Schmidt, Willburger et al., 1999; Mandl et al., 2002; Chung et al., 2004; 
Moller et al., 2005; Chung et al., 2009; Escott et al., 2010). In the study by Tägil et 
al. (2009) improved aesthetics correlated positively with most of the subjective 
outcome variables. 
The outcome after silicone MCP joint arthroplasty deteriorates over long-term 
follow-up. Goldfarb and Stern (2003) reported that only 28% of patients were pain 
free and 38% were satisfied with function at 14-year follow-up. Extension lag 
deteriorated from postoperatively achieved 11° to 23° and ulnar deviation from 5° to 
16°, but in both variables final assessments were still better than the preoperative 
values (Goldfarb & Stern, 2003). Wilson et al. (1993) reported recurrence of ulnar 
deviation over 20° in 43% of cases at 14-year follow-up. Survival at five years using 
revision surgery as an endpoint has been reported to be 92-97% and at 10 years 83-
90% (Hansraj et al., 1997; Trail et al., 2004; T. J. Parkkila et al., 2006), but using 
fracture of the implant as the endpoint survival deteriorated to 58% at 10 years 
(Trail et al., 2004), (Table 3). Silicone synovitis does not appear to be a critical issue 
for silicone MCP joint arthroplasty, however, even silicone lymphadenopathy has 
been reported at distant locations (Paplanus & Payne, 1988; Abboud et al., 2003; 
Trail et al., 2004).  
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Table 3.   Summary of studies presenting fracture rate after silicone MCP joint arthroplasty in rheumatoid patients 
 
N Follow-up Study Implant  
Patients Joints (months) 
Probable 
fracture 1 
(%) 
Fracture 
(%) 
Osteolysis 
(% of joints ) 
Survival % 2        
(revision ) 
Survival % 3      
(fracture) 
Vahvanen and 
Viljakka (1986)  
Swanson 32 107 45 10 4 24  96 
Kirschenbaum et al. 
(1993) 
Swanson 27 144 102  10 100 4  90 
Wilson et al. (1993) Swanson 35 375 168 17 6 14  94 
34 168 27 10 20   80 Bass et al. (1996) Avanta 
10 40 36 5 45   55 
Gellman et. (1997) Swanson 264 901 96  14   86 
Hansraj et al. (1997) Swanson 71 170 63 28 0.7 8 5yrs 94%, 10yrs 90% 94 
Schmidt et al. 
(1999) 
Swanson 28 102 102  27 89  73 
Goldfarb and Stern 
(2003) 
Swanson 36 208 168 22 63 29  37 
204 66 63 34 Trail et al. (2004) Swanson 381 1336 
120 
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83 58 
Delaney et al. 
(2005) 
Swanson/ 
NeuFlex 
10/12 37/40 24  0/0   100 
Möller et al. (2005) Swanson/ 
Avanta 
30 120 24 15/13 13/20   87/80 
Parkkila et al. 
(2006) 
Swanson/ 
Avanta 
53 89/126 58 35/26 34/26  92/97 66/74 
Pettersson et al. 
(2006) 
NeuFlex/ 
Avanta 
40 78/78 12  3/6  100 97/94 
Tägil et al. (2009) Swanson/ 
Avanta 
18 72 60  11/36   89/64 
1 
 in addition to confirmed fracture  
2 
 revision as endpoint 
3 
 fracture of the implant as endpoint 
4   some erosion of the metacarpals and the proximal phalanx   
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4.3.3 Radiological results 
Silicone implants have been associated with progressive bone destruction and 
implant fracture, but bone erosions and osseous architecture vary considerably after 
silicone MCP joint arthroplasty and are difficult to quantify accurately and 
objectively (Kirschenbaum et al., 1993). Definition of implant fracture in plain x-
rays is difficult, thus in many studies the following three-step classification has been 
used: definitely fractured implants, possibly fractured (=severely deformed) 
implants and intact implants. According to the widely used criteria of Bass et al. 
(1996) a definite implant fracture is noted (1) when there are lucent lines or 
fragmentation of the midportion of the implant, (2) when there is a translation in the 
coronal or sagittal plane of the base of the proximal phalange relative to the neck of 
the metacarpal of more than one-half the diameter of either bone and (3) when there 
is a proximodistal overlap of the base of the proximal phalange and the neck of the 
metacarpal of more than one-half of the width of the midportion of the implant. CT 
scan has also been used to improve the accuracy of implant fracture diagnosis 
(Sollerman & Geijer, 1996; Tagil et al., 2009). The majority of fractures occur at the 
junction of the distal stem and the hinge (Trail et al., 2004). 
 
  
Figure 6.  Fractured Swanson implants from one patient’s MCP joints obtained in revision 
operation 
  
 
 
 
Implant fracture rate is low, from 0 to 17%, in short-term studies, but increases 
over time, and in studies with long-term follow-up (14 and 17 years) implant 
fracture rates as high as 63-66% have been reported (Schmidt et al., 1999; Goldfarb 
& Stern, 2003; Trail et al., 2004; Moller et al., 2005; Escott et al., 2010). In a 
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randomised study comparing Swanson and Sutter implants (Parkkila et al. 2006), 
fracture rates assessed according to Bass et al. (1996), were 34% in the Swanson 
group and 26% in the Sutter group at four-year follow-up, but the difference 
between the groups was not statistically significant. Comparable fracture rates were 
reported in an RCT by Tägil et al. (2009) using CT scan for fracture diagnosis. At 
five years 11% of the Swanson implants and 36% of the Avanta (Sutter) implants 
were broken (P=0.05) but fractures did not change the subjectively assessed 
outcome (Table 3).  
The loss of alignment in the wrist has been reported to be an important factor for 
failure in long-term outcome after MCP arthroplasty (Ruther et al., 1995). 
According to Trail et al. (2004), the greater the radial deviation malposition of the 
wrist was, the more likely was the implant to break and require revision. Men had a 
greater risk of implant fracture than women (Moller et al., 2005). The wider 
postoperative ROM at three months was reported to represent a risk of implant 
fracture. An increase in ROM later during follow-up has been figured to be a 
consequence of implant fracture (Tagil et al., 2009). The preoperative deformity 
degree showed no correlation with implant fracture in a prospective study by Möller 
et al. (2005), but the number of fractured implants was low (20).  In a retrospective 
study by Trail et al. (2004) in which 76 out of 1,336 implants were revised and 66% 
of the implants were radiographically fractured after 17 years of follow-up, the less 
the preoperative ulnar deviation was, the lower were the fracture and revision rates.  
The morbidity associated with the fractured prosthesis is not very high because 
the implant functions as a spacer rather than as an articulating prosthesis, and scar 
tissue formation around the implant called “encapsulation” supports the joint 
(Abboud et al., 2003; Joyce, 2004). The status of the implant does not significantly 
affect the ROM of the MCP joint in the long term (Goldfarb & Stern, 2003; Moller 
et al., 2005) but recurrence of ulnar deviation is more common in fractured implants 
than in non-fractured implants (Bass et al., 1996; Goldfarb & Stern, 2003; Tagil et 
al., 2009). Ulnar drift impairs cosmetic appearance, and cosmetic appearance has 
been reported to be negatively related to implant fracture (Moller et al., 2005).  
Silicone implants are known to cause osteolysis around the implant and bone 
shortening of the metacarpal and proximal phalanx at long-term follow-up, but the 
incidence of these changes after silicone MCP arthroplasty varies widely in different 
studies. Osteolytic changes were reported even in 89% of joints in the studies in 
which implants were produced of previously used silastic elastomer (Schmidt, 
Willburger et al., 1999), but also in series with the currently used silastic elastomer 
considerable effects on adjacent bone have been reported (Moller et al., 2005; 
Parkkila et al., 2006). In the study by Goldfarb and Stern (2003) at 14 years 
postoperatively the final metacarpal length was 90% of the length of the metacarpal 
immediately postoperatively, and the length of the proximal phalanx was 94% of the 
preoperative length. The majority of patients showed a moderate loss in bone 
lengths, but in six out of eighteen hands the metacarpal length was decreased by > 
16% and by > 25% in three out of eighteen hands. They also reported significant 
loss in the MCP joint space width (subsidence) comparing the measurements 
performed immediately after surgery to those performed during final follow-up 
(Goldfarb & Stern, 2003). The incidence of osteolysis after MCP arthroplasty was 
evaluated in a prospective, randomised study in Swanson and Sutter prostheses 
(Parkkila et al. 2005) in which 75 Swanson implants and 99 Sutter implants were 
radiographically evaluated at 58 months postoperatively. The Sutter group had a 
significantly increased rate of osteolysis when compared with the Swanson group. 
40 
In the Swanson group 60% of metacarpal bones were free of osteolytic changes, 
whereas only 23% of metacarpals were intact in the Sutter group. Osteolysis 
perforating the cortex was reported in 5% of the Swanson implants and in 30% of 
the Sutter implants. In another study by the same research group 282 Sutter implants 
were evaluated after a mean of 5.7 years, and osteolytic changes were present in 
50% of metacarpal and in 54% of phalangeal bones. They found that osteolysis was 
more severe in the fractured implant cases. There was also a correlation between 
osteolysis and hand dominance. They concluded that in the dominant hand 
prostheses are exposed to more use, and this may be the cause of the correlation 
with the osteolysis (Parkkila et al., 2006).  
It has been claimed that implants which provide long-term stability with less 
bone reaction are needed (Goldfarb & Dovan, 2006), and the Swanson prosthesis 
can be viewed as offering a known performance – a benchmark against which other 
MCP prostheses can be judged. The Swanson prosthesis poses a challenge to 
implants, and not only by the easiness of implantation and good cost-effectiveness 
(Joyce, 2004). 
 
 
 
5. Bioabsorbable polymers in orthopaedic 
implants 
 
5.1 Material and properties 
In the last few decades bioabsorbable polymers and composites have been 
investigated in an attempt to achieve an implant the biodegradation of which would 
accompany the regeneration of the damaged tissue. The goal of non-degradable 
implants is to replace the damaged tissue but they have only a limited ability to 
integrate with the adjacent tissue and to transfer the mechanical loads appropriately 
to the surrounding tissues. The aim of biodegradable materials is to act as a physical 
support for the repairing tissue with the ability to promote cell adhesion, 
proliferation and differentiation. More recently, biomolecules, such as drugs and 
growth factors, have been added to stimulate and regulate the activity of the cells 
entrapped in the bioabsorbable biomaterial scaffolds (Koort, Makinen, Suokas, 
Veiranto, Jalava, Tormala, & Aro, 2008; Santin , 2009.)  
Bioabsorbable sutures have been routinly used in clinical surgery for over 30 
years. In orthopaedic surgery bioabsorbable implants are available for the 
stabilisation of fractures, osteotomies, bone grafts and fusions, as well as for 
reattachment of ligaments, tendons, meniscal tears and other soft tissue structures. 
Bioabsorbable implants should have adequate initial mechanical strength, but lose 
their strength gradually during the healing process to enable uncomplicated tissue 
repair. Avoidance of implant removal operation is one of the advantages of 
biodegradable devices and highly valued, especially in cranio-maxillofacial and 
paediatric surgery. The bioabsorbable polymers most intensively studied for the 
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manufacture of implants and for surgical use are poly-α-hydroxyacids, especially 
polyglycolide (PGA), polylactide (PLA) and their copolymers. PGA is relatively 
hydrophilic, highly crystalline, and degrades and loses its strength rapidly in the 
body, which may lead to fluid accumulation and sterile sinus formation. PGA as a 
homopolymer is nowadays used mainly in paediatric surgery and also in other 
applications when glycolide is copolymerised with lactides to form polylactide-
glycolide copolymers (Waris, Konttinen, Ashammakhi, Suuronen, & Santavirta, 
2004). Lactic acid monomer occurs in two stereoisomeric forms, L- and D-lactic 
acid, and lactide dimer in LL, DD and DL forms. The L-isomeric form of 
polylactide (PLLA) is relatively hydrophobic and partially crystalline, and therefore, 
its complete biodegradation and bioabsorption takes several years. By combining D-
isomers with L-lactic acid, copolymers of DD-, DL- and LL-lactide e.g. (P(L/D)LA) 
can be manufactureded which biodegrade more rapidly than pure PLLA. Various 
degradation rates of the polymer can be achieved by varying the percentage of each 
component (L or D) in the polymer structure. In fracture fixation the mechanical 
strength of the implant is important; whereas porous scaffolds have been used to 
guide tissue growth in bone defects and high initial strength is not in all cases such a 
critical property (Kellomaki, Niiranen, Puumanen, Ashammakhi, Waris, & Tormala, 
2000). These different bioabsorbable polymers can be engineered to alter their 
material properties and degradation characteristics (Ambrose, & Clanton, 2004). 
The most commonly used devices in orthopaedic surgery are made of poly L-lactide 
(PLLA) and different copolymers of polylactides (P(L/D)LA) and polyglycolide 
(PLGA), and pins, rods, screws, miniplates, tacks and anchors have been 
manufactured (Middleton & Tipton, 2000; Ashammakhi, Suuronen, Tiainen, 
Tormala, & Waris, 2003).  
Biodegradation of poly-α-hydroxyacids generally occurs in two phases. It begins 
with hydrolysis of the polymer chains, leading first to a reduction in molecular 
weight, followed by loss of the mechanical strength. In the second phase the implant 
loses its form and disintegrates physically into small particles, and finally into 
oligomers and monomers which are eliminated through normal metabolic pathways 
(Ambrose & Clanton, 2004). Biodegradation is influenced by chemical and physical 
factors, such as the chemical composition of the polymer, its molecular weight and 
orientation, monomer concentration, geometric isomerism, crystallinity, volume and 
porosity of the implant, the sterilisation method, and the presence of impurities in 
the polymer. Environmental factors, such as implantation location, mechanical 
stress transferred to the device, and vascularity in the implantation site also affect 
the biodegradation process (Kellomäki & Törmälä, 2003). Degradation is generally 
faster in vivo than in vitro, in human tissues than in animal experiments, and in well 
vascularised cancellous bone than in subcutaneous tissue (Middleton & Tipton, 
2000; Ambrose & Clanton, 2004; Waris et al., 2004). 
Adverse tissue reactions, such as fluid accumulation, sinus formation and 
osteolysis, have been reported around bioabsorbable implants, especially if 
produced from pure homopolymeric PGA or PLLA. The newer generation 
bioabsorbable copolymers are generally well tolerated by living tissues, but tissue 
reaction to bioresorbable implants occurs to some extent with most of the currently 
available materials (Ashammakhi et al., 2003; Ambrose & Clanton, 2004). The 
reported incidences of inflammatory reactions to newer copolymers have been low. 
These reactions have not been accompanied by clinical symptoms and have had no 
clear effect on the final outcome (Joukainen, Pihlajamaki, Makela, Ashammakhi, 
Viljanen, Patiala, Kellomaki, Tormala, & Rokkanen, 2000; Ashammakhi, 
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Peltoniemi, Waris, Suuronen, Serlo, Kellomaki, Tormala, & Waris, 2001; 
Ashammakhi et al., 2003; Lazennec, Madi, Rousseau, Roger, & Saillant, 2006). 
However, cases where bioabsorbable devices had to be removed due to major 
inflammatory reactions have also been reported (Chen, Chang, Lu, Chang, Tsai, & 
Huang, 2010; Givissis, Stavridis, Papagelopoulos, Antonarakos, & Christodoulou, 
2010). Despite the variable clinical picture of the tissue reactions, the histologic 
picture is consistent: a sterile, nonspecific inflammatory response with multinuclear 
foreign body giant cells. Polymeric debris is usually visible and osteolytic lesions 
are often found. The timing of the foreign-body response is thought to be related to 
the two phases of polymer degradation (Ambrose & Clanton, 2004). The risk of 
adverse tissue reactions increases if the implant volume is high and debris particles 
are produced rapidly, and if the clearing capacity of the surrounding tissue is 
exceeded. Poor vascularity and a thin soft tissue layer at the implantation site 
decrease the clearing capacity of the tissue (Ambrose & Clanton, 2004; Givissis et 
al., 2010). 
  
5.2 96L/4D poly-L/D-lactide copolymer  
At the beginning of the 1990’s a fibrous cushion made of commercially available 
PGA (90% glycolide and 10% L-lactide) sheets (Vicryl® and Ethisorb®) was 
introduced for revision and badly destroyed MCP joint arthroplasties in rheumatoid 
patients by a group of orthopaedic researchers in Tampere University Hospital 
(Lehtimaki, Lehto, Kellomaki, Paasimaa, Makela, Honkanen, & Törmälä, 1998). 
The biodegradable cushion was intended to act as the tendon, mimicking Vainio 
arthroplasty (Vainio, 1989), and the aim was to find a material that could work as a 
scaffold for the fibroblast proliferation and connective tissue ingrowth. Unpublished 
observations showed that the resorption time of both commercial materials was 
discovered to be too short, which led to premature collapse of the joint space. 
However, the research and development work in Tampere University Hospital 
continued in collaboration with the biomaterial research group of Tampere 
University of Technology, with the aim of developing a bioresorbable implant with 
suitable mechanical properties coupled with optimal degradation rate so that the 
implant would enable ingrowth of host tissue into the scaffold. The first implant 
shape was a rectangular cushion, but soon the circular, highly porous, disc-like 
implant made of poly-L/D-lactide copolymer fibres with an L:D monomer ratio of 
96:4 was designed (96L/4D poly-L/D-lactide copolymer).  
The same copolymer has been in clinical use in meniscus arrows, in nails and in 
suture anchors, and the first commercial implants made of this material have been in 
the market since 1999. 96L/4D poly-L/D-lactide copolymer has been studied in 
several experimental indications and with cells in vitro. These studies have shown 
that 96L/4D poly-L/D-lactide copolymer is non-cytotoxic and supports attachment 
and ingrowth of tissue. Typical histological findings are mild tissue reactions, 
reaching their peak around 24 weeks then subsiding for up to 54 weeks. 
Macroscopic degradation of the material is achieved by 156 weeks (Cordewene, van 
Geffen, Joziasse, Schmitz, Bos, Rozema, & Pennings, 2000; Saikku-Backstrom, 
Tulamo, Raiha, Kellomaki, Toivonen, Tormala, & Rokkanen, 2001; Maenpaa, Ella, 
Mauno, Kellomaki, Suuronen, Ylikomi, & Miettinen, 2010).  
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In vitro experiments have shown that the filaments retain at least 50% of their 
tensile strength for 13 weeks, and scaffolds retain their shape for at least the same 
length of time (Paatola, Kellomäki, & Törmälä, 2000; Ellä, Annala, Länsman, 
Nurminen, & Kellomäki, 2011). In animal tests some connective tissue ingrowth 
into the mesh structure was already observed after the first week. 96L/4D poly-L/D-
lactide copolymer scaffolds implanted in rat subcutis were filled with fibrous tissue 
by 3 weeks, and at 24 weeks each PLDLA filament within the bundle of PLDLA 
fibres was surrounded by a thin layer of fibrous connective tissue. Fibrous tissue 
collagen fibres became more organised over time. At 48 weeks a dense connective 
tissue capsule had formed around each PLDLA fibre and around each individual 
PLDLA filament (Kellomäki, Puumanen, Waris, & Törmälä, 2000; Lansman, 
Paakko, Ryhanen, Kellomaki, Waris, Tormala, Waris, Ashammakhi, 2006).  
 Waris and co-workers (2008) compared the biological behaviour, bioabsorption 
and biocompatibility of bioreconstructive and Swanson silicone interposition 
arthroplasties in the fifth MCP joints of minipigs. The 96L/4D poly-L/D-lactide 
copolymer joint scaffold maintained the width of the arthroplasty joint space and 
induced fibrous tissue ingrowth in situ. The porous structure of the scaffold was 
finally completely invaded by loose fibrous tissue, which along with the degradation 
of the scaffold matured and condensed into dense fibrous connective tissue. The 
collagen framework was more prominent on the volar side of the scaffold than on its 
dorsal side, which was interpreted so that compression loading associated with joint 
flexion stimulates fibrogenesis. Collagen fibres were oriented in a longitudinal 
fashion adapting to the flexion-extension movements of the joint. No differences 
were noted in ROM or stability between the 96L/4D poly-L/D-lactide copolymer 
scaffold and Swanson groups. In the Swanson implant group one minipig developed 
a sinus at the operation site two months postoperatively, but in the 96L/4D poly-
L/D-lactide copolymer scaffold group no adverse tissue reactions were noted 
(Waris, Ashammakhi, Lehtimaki, Tulamo, Kellomaki, Tormala, & Konttinen, 
2008). 
 96L/4D poly-L/D-lactide copolymer joint scaffolds were almost completely 
degraded at three years (Waris et al., 2008), which is comparable to reports with 
96L/4D poly-L/D-lactide copolymer rods in osteotomy surgery in sheep and rabbits 
(Saikku-Backstrom et al., 2001; Saikku-Backstrom, Tulamo, Raiha, Pohjonen, 
Toivonen, Tormala, & Rokkanen, 2004). Resorption of the 96L/4D poly-L/D-lactide 
copolymer cushions evaluated by histolgical data, CT and MRI was reported in 
sheep spinal fusion to be complete at 3 years (Lazennec et al., 2006). No 
inflammatory reactions developed in the tissues surrounding the 96L/4D poly-L/D-
lactide copolymer implants or they have been mild in animal experiments (Isotalo, 
Alarakkola, Talja, Tammela, Valimaa, & Tormala, 1999; Saikku-Backstrom et al., 
2001; Saikku-Backstrom et al., 2004; Lansman et al., 2006; Lazennec et al., 2006; 
Waris et al., 2008).  
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AIMS OF THE STUDY 
 
The aim of this study was to investigate the clinical value of partial radiocarpal wrist 
arthrodesis in rheumatoid hand disease and the outcome of a novel bioabsorbable 
implant in MCP joint replacement surgery in rheumatoid arthritis patients. The 
specific aims were: 
 
1. To analyse the effect of partial radiocarpal arthrodesis in a 
prospective midterm study with respect to clinically relevant 
parameters, alignment, pain and range of motion  
2.  To analyse the short-term biocompatibility and function of an 
implant produced of 96L/4D poly-L/D-lactide copolymer in an open 
clinical trial in the treatment of metacarpophalangeal joints in 
rheumatoid arthritis patients 
3.  To analyse the mid-term clinical performance of the abovementioned 
MCP implants, including evaluation of eventual peri-implant 
osteolysis developing as a result of resorption of the 96L/4D poly-
L/D-lactide copolymer implants at the timepoint when they are 
already totally resorbed 
4.  To compare the novel 96L/4D poly-L/D-lactide copolymer implant 
with the conventional silastic Swanson implant in MCP joint 
arthroplasty 
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MATERIAL AND METHODS 
 
 
 
1. Patient selection and study design 
 
The thesis is composed of three different patient materials. Only patients with 
inflammatory arthritis diagnoses were included. In the first material all patients 
undergoing radiocarpal arthrodesis in the Department of Orthopaedics in Tampere 
University Hospital between 1995 and 1999 were recruited for a prospective study. 
The patient material included 23 patients and 26 wrist joints. The indication for the 
operation was pain or chronic wrist synovitis with radiocarpal destruction or 
dislocation of the radiocarpal joint seen in X-rays. Defects of the cartilage in the 
midcarpal joint visible in routine radiographs were considered to be a 
contraindication for this operation. Outcomes of 23 wrists in 20 patients were 
evaluated at a mean of 5.8 years follow-up.  
The patient material in Studies II and III was composed of 23 consecutive 
rheumatoid arthritis patients who between 1997 and 2000 underwent primary or 
revision MCP arthroplasty in 80 joints with novel bioabsorbable implants made of 
96L/4D poly-L/D-lactide copolymer. The indication for the operation was 
rheumatoid deformation of the MCP joints affecting ADL. Results of 54 joints in 15 
patients were reported at a minimum of 1 year follow-up, and the outcome of 23 
patients (80 joints) was presented at mean 59 months after operation, which exceeds 
the resorption time of 96L/4D poly-L/D-lactide copolymer implants according to 
earlier published animal experiments.  
The third patient material in Study IV was recruited for a randomised parallel 
group trial, carried out at two centres, Tampere University Hospital and the 
Rheumatism Foundation Hospital in Heinola. The inclusion criterion was 
rheumatoid arthritis in MCP joints impairing ADL. Second or later revision 
operations were excluded. Randomisation was done using a random digit table and 
allocation concealment using sealed sequentially numbered envelopes. Patients were 
randomised to either the investigational device (bioabsorbable 96L/4D poly-L/D-
lactide copolymer implant) or the comparator device (conventional silicone 
Swanson prosthesis) groups. Results in 52 patients (53 hands and 175 joints) at a 
mean follow-up of 2 years were evaluated. 
All patients were informed of the study protocol and written consent was 
obtained from each patient. Studies I-IV were approved by the Ethics Committee of 
the Tampere University Hospital and Pirkanmaa Hospital District, and Study IV 
also by the Ethics Committee of Päijät-Häme Central Hospital and Päijät-Häme 
Social and Health Care District. In addition, the approval from the Finnish Medicine 
Agency was obtained for Study IV.  
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2. Bioabsorbable MCP implant scaffold 
2.1 Manufacturing 
The investigational implants were manufactured at the Institute of Biomaterials, 
Tampere University of Technology. The polymer used in these studies was 
medicalgrade and highly purified (residual monomer content 0.1% according to the 
manufacturer) polylactide L- and D-copolymer with an L:D monomer ratio of 96:4 
(PLA96; Purac Biochem, Gorinchem, The Netherlands). After pre-drying the 
polymer was melt-spun to 4-filament fibre. This process was initially performed 
using an Axon BX-15 single screw extruder (screw diameter 15 mm; ratio of screw 
length to diameter 24; Axon, Åstorp, Sweden) with a spinneret with four orifices 
(each with a diameter of 0.5 mm). The PLA96 used in Study IV was processed to 4-
filament fibres using Gimac microextruder (Gimac, Gastronno, Italy) with a screw 
diameter of 12 mm and single orifice diameter of 0.4 mm. Four-ply multifilament 
yarn was knitted to a tubular mesh, using a tubular single jersey knitting machine 
with a ½” needle barrel (Elha R-1S, Textilmaschinenfabrik Harry Lucas, 
Neumünster, Germany). The knitted tube was reeled to circular cushion-like 
implants and heat-treated above the glass transition temperature of polymer in 
molds. In the beginning the reeling process was performed manually, but this 
production step was later performed using semiautomatic reeling equipment. The 
porosity of the scaffolds was assessed by determining the weight and size of the 
scaffolds and calculating against the solid piece of PLA96. The single-packed 
implants were sterilised by γ-irradiation (commercial service supplier, nominal 
irradiation dose 25 kGy). 
 
2.2 Implant properties 
The circular, disc-like 96L/4D poly-L/D-lactide copolymer implant scaffolds used 
in these studies were made of the same material that has been in the market and used 
in various devices for bone and soft tissue fixation since the late 1990s.  
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Figure 7.  PLDLA bioabsorable MCP joint implant 
   
 
 
The 96L/4D poly-L/D-lactide copolymer joint scaffold is knitted and highly porous, 
enabling needle perforation during surgical fixation, and the implant is clearly 
flexible. The properties of the implants were found to enable fibrous tissue growth 
into the implant and the implant has good biocompatibility with bone tissue. 
Implants with diameters of 12, 14, 16 and 18 mm having a nominal thickness of 4.5 
mm (range 4.3–4.7) were used in these studies. The purpose was to use an implant 
size as close to the joint size as possible. The stemless implant enables bone grafting 
into medullar canals in the same operation.  
 
3. Surgical technique and postoperative 
rehabilitation 
3.1 Partial radiocarpal arthrodesis 
Anaesthesia was mainly produced by plexus block. All operations were performed 
using a tourniquet, and a prophylactic antibiotic (cefuroxime) was used 
preoperatively. Synovectomy of the extensor tendons and radiocarpal, midcarpal 
and radioulnar joints were routinely performed in all cases. A segment of the 
posterior interosseous nerve was resected in all cases. Ulnar head resection was 
performed in all cases except one. Capsule opening was performed using a mildly S-
shaped longitudinal incision. In radiolunate arthrodeses, the surface of the lunate 
fossa of the radius and the surface of the lunate bone in contact with it were resected 
back to the cancellous bone, but the contours of the bones were maintained as well 
as possible. In radioscapholunate arthrodesis, the contact surfaces of the scaphoid 
fossa of the radius and of the scaphoid bone were also similarly prepared. Reduction 
of the lunate bone in radiolunate arthrodesis cases, or of both the lunate and the 
scaphoid bones in the radioscapholunate arthrodesis cases, was performed to correct 
the ulnar translocation and palmar subluxation malalignments of the wrists. Volar 
and dorsal intercalated segmental instabilities (VISI and DISI) of the lunate were 
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carefully corrected. Compression and temporary fixation were achieved with AO-
forceps and two short 0.8 mm K-wires. The alignment of the capitate bone in 
relation to the scaphoid and the lunate was evaluated in flexion–extension motion. If 
any torque seemed to exist, their relative position was adjusted. Reposition was also 
checked with C-arm imaging before final fixation. Bone grafting was not routinely 
used, but any space between the bones to be fused was filled with bone graft 
obtained from the resected ulnar head. The lunate, or both the lunate and scaphoid 
bones were fixed to the radius. In 16 cases this fixation was performed with metal 
staples, in six cases with bioabsorbable Biofixs rods and in one case both devices 
were used (Figure 8). The extensor retinaculum was split transversely and the 
proximal part was stitched under the extensor tendons to stabilise the distal ulna. 
The distal part of the retinaculum was reattached dorsally to the extensor tendons to 
prevent the bowstring phenomenon. Bulky dressings and a dorsal plaster cast were 
applied at the end of the operation. These were replaced by a dorsal individual static 
splint on the second postoperative day and this splint was used for six weeks, during 
which time only light use of the hand was permitted.   
 
 
Figure 8.  X-ray of radiolunate arthrodesis pre- and postoperatively 
  
3.2 MCP arthroplasty with Swanson and MCP scaffold 
implant 
Regional plexus anaesthesia was administered by anaesthesiologists. A preoperative 
prophylactic antibiotic was routinely used. Operations were performed using a 
tourniquet. Transverse skin incision was performed over the knuckles. The extensor 
hood was opened longitudinally from the radial side in Studies II-III, and either a 
radial or ulnar approach was used in Study IV. The joint capsule was opened 
longitudinally and synovectomy was carried out. The metacarpal head was resected 
just distal to the collateral ligament insertions both in Swanson and PLDLA 
arthroplasty. The quantity and quality of soft tissue balancing in the operation were 
determined by analysis of the grade and type of the deformity. When ulnar deviation 
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existed, the proximal bony attachment of ulnar collateral ligament was released. 
Deliberation of the volar capsule under the metacarpal bone and release of the volar 
plate were performed to achieve adequate correction of volar subluxation. Ulnar 
intrinsic muscle contractures were released when required. The abductor digiti 
minimi of the fifth finger was always dissected. The 96L/4D poly-L/D-lactide 
copolymer scaffold was fixed with absorbable sutures through the metacarpal bone 
via the volar plate.  
 
Figure 9.  Surgical technique for primary MCP arthroplasty using P(L/D)LA 96/4 scaffolds 
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Intramedullary bone grafting using morcelised allograft and/or autograft bone was 
performed in revision arthroplasties. Balancing and tightening of the collateral 
ligaments were performed by duplicating or refixing the ligament more proximally 
through drill holes in the proximal metacarpal bone. At the end, the extensor tendon 
was centralised. 
In rehabilitation, the operated MCP joints were supported with a palmar static 
splint at night. Active and passive range of movement exercises were assisted with 
low-profile dynamic dorsal splinting starting 10 days postoperatively and continued 
for up to 12 weeks (Figure 10). Light ADL, like eating and personal hygiene, was 
allowed immediately after the use of the dynamic splint was initialised. The 
rehabilitation was controlled by an occupational therapist.  
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Figure 10.  Volar static and dorsal dynamic splints in rehabilitation after MCP joint 
replacement surgery 
 
 
 
 
4. Clinical examination 
4.1 Evaluation of alignment and range of motion 
The range of motion of the MCP joints was evaluated by measuring active flexion 
and lack of active extension from the dorsal side using a goniometer. The deficiency 
in total finger flexion was recorded in Study III using the distance between finger 
tips and the distal palmar crease. The active ROM of the wrist was measured 
dorsally using a goniometer. Ulnar deviation, the angle between the metacarpal and 
the proximal phalangeal bone, was measured clinically using a goniometer and with 
the fingers in maximal active extension. The measurements were performed 
preoperatively and postoperatively at the follow-up visits.  
 
4.2 Evaluation of functionality of the hand 
4.2.1 Functional grips 
Grip strength was measured using a Jamar dynamometer (Preston, Jackson, MI, 
USA) with the handle in position two. The mean value of three grip strength 
measurements was calculated in Studies II and III, and the best value of three 
consecutive measurements was recorded in Studies I and IV. The postoperative 
measurements of the hand operated on were compared to preoperative assessments 
and to the postoperative measurements of the contralateral hand. Tip pinch grip was 
assessed for each finger with a wooden bead of 10 mm diameter and graded as 
normal, applied or not able.  
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4.2.2 ADL abilities and activities 
The functionality of the hand in ADL was evaluated pre- and postoperatively by an 
occupational therapist in Studies II, III and IV. A therapist performed simulated 
ADL tests, such as ability to handle a knife and fork (precision grip) and a jug with 
capacity of 0.5 litres (cylinder and transverse volar grip). In the precision grip 
assessment the patient used a knife and fork to cut a piece of resistive exercise putty 
(Rolyan A497-280, diameter 7.5 cm). In the cylinder grip test the patient was asked 
to decant 1 dl of water from a jug to a glass (diameter 6–7 cm), whereas decanting 
the water back to the jug was assessed as a transverse palmar grip. These functional 
grips were graded as normal, alternative way or not able, and the alternative way 
meaning to be able to perform the task but not in the manner requested. The timed 
‘Box and Block’ (in Studies II, III and IV) and ‘Nine hole’ (in Studies II and III) 
tests were performed pre- and postoperatively by both hands separately to evaluate 
the change in the dexterity of the hand operated on. Ability to take care of personal 
hygiene, dressing, eating and housework were assessed by questioning and graded 
‘no difficulties’, ‘some difficulties’, and ‘considerable difficulties’ or ‘not able to 
do’ (in Studies II and III).  
 
4.3 Evaluation of subjective outcome 
Pain and satisfaction were assessed using a questionnaire. A verbal rating scale for 
pain evaluation was used in Studies I-III, and the visual analogous scale (0-100, 0 
indicates no pain) was used in Study IV. Patient satisfaction was assessed using a 
scale reporting excellent, good, satisfactory or poor results. 
 
4.4 Complications and adverse events 
Infections and any kind of wound healing problems were recorded as complications, 
and likewise abnormal tissue reactions (swelling or redness) in Studies II-IV.  
 
 
 
5. Radiological evaluation 
 
Standardised anteroposterior, supine oblique and lateral X-rays of the hand and 
wrist were taken preoperatively and at the follow-up visits postoperatively. The 
supine oblique projection was taken using a cradle to enhance the repeatability. 
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Preoperatively, structural changes of the MCP joints and the wrist were graded 
using the Larsen score. 
 
5.1 Evaluation of consolidation 
In the partial wrist fusion study (Study I) the consolidation of the arthrodesis at the 
follow-up was evaluated in radiographs. The incorporation of the bone grafts was 
evaluated in radiographs in the revision cases.  
 
5.2 Evaluation of the correction of the malalignment 
The carpal ulnar distance ratio (Youm, McMurthy, Flatt, & Gillespie, 1978) was 
used to measure ulnar translocation before partial wrist arthrodesis operation and to 
assess the correction of the malalignment at follow-up. Volar and dorsiflexed 
intercalated segmental instabilities (VISI and DISI) of the lunate were measured to 
evaluate the dislocation of the wrist on the frontal axis. The carpal height ratio was 
used to reflect the cartilage and bone destruction stage in the wrist joint as well as 
palmar dislocation of the carpal bones.  Ulnar and radial deviations of the wrist pre- 
and postoperatively were evaluated by measuring the angle between the longitudinal 
axis of the third metacarpal bone and that of the radius in the anteroposterior 
projection.  
Palmar subluxation of the MCP joints was assessed from standardised supine 
oblique radiographs with the fingers at maximal active extension. The difference 
between the dorsal levels of the metacarpal bone and proximal phalanx was 
measured in millimetres (Study II) or graded as ‘no palmar subluxation’, ‘palmar 
subluxation’ and ‘dislocation’ (Study IV) or graded as ‘no subluxation’, 
‘subluxation less than 50% of metacarpal thickness’, ‘subluxation more than 50% of 
metacarpal thickness’ and ‘complete dislocation’ (Study III). In the dislocation 
category the dorsal cortex of the proximal phalanx lay under the palmar cortex of 
the metacarpal bone. 
 
5.3 Evaluation of progression of joint deterioration 
In the partial wrist arthrodesis study the degree of midcarpal joint destruction in the 
wrist was evaluated at final follow-up from the supine oblique and anteroposterior 
projections and categorised into three groups, viz. intact midcarpal joint space, 
narrowed midcarpal joint space and destroyed midcarpal joint, in which erosions or 
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other bone deformities were observed. The effect on clinical outcome of the 
midcarpal joint destruction after partial wrist arthrodesis was evaluated.  
 
5.4 Evaluation of osteolysis 
The joint space indicating the distance between the metacarpal and proximal 
phalanx bone ends in supine oblique radiographs from the radioulnar middle point 
of the joint was measured preoperatively. This was compared with the final follow-
up value after the MCP joint arthroplasty to reflect the osteolysis of the metacarpal 
or proximal phalangeal bone. The maximal depth of osteolysis at the ends of the 
metacarpal and proximal phalangeal bones was measured from both projections. In 
addition, implant fractures and cortical bone perforations were evaluated from 
radiographs 
 
 
 
6. Statistical methods 
 
The numerical variables were presented as means with standard deviations (or 
range) or as medians and quartiles depending on data distribution. The categorical 
variables were reported as absolute and relative frequencies. Unpaired t-test and 
one-way ANOVA were used to analyse differences between groups for normally 
distributed variables, whereas skewed data were analysed with Mann–Whitney test.  
Analyses between pre- and postoperative nonparametric variables were made with 
Wilcoxon test and in case of numerical and normally distributed variables paired 
samples t-test was used. Categorical variables were analysed using crosstabulations 
with Fisher’s exact test. In comparing classified variables pre- and postoperatively 
in case of small sample size κ- and γ-statistics were used. Spearman’s correlation 
coefficient was used to analyse the strength of the associations for skewed variables, 
whereas Pearson’s r was used for normally distributed variables. SPSS for 
Windows statistical software (Chigaco, IL, USA) was used to analyse the data. 
Sample size estimation was performed in Study IV using active ROM in the 
MCP joint as a primary outcome. A difference of 10° (and standard deviation of 
15°) was considered to be a clinically significant difference between the groups. 
After power calculations using 5% type I error, 80% power and 0.10 effect size, 80 
patients were recruited to allow a safety margin for drop-outs. 
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SUMMARY OF THE RESULTS 
 
 
 
1. Clinical and radiological outcome of 
partial radiocarpal arthrodesis in the 
treatment of instable rheumatoid wrist 
(Study I) 
 
The subjective outcome after partial radiocarpal arthrodesis was good. Significant 
pain alleviation was achieved (p=0.001) so that 17 out of the 23 wrists operated on 
were painless at final follow-up (mean 5.8 years). Patient satisfaction was excellent 
or good for 20 wrists and satisfactory for one wrist. In two patients with poor 
satisfaction, arthritis progressed to the midcarpal joint and necessitated total 
arthrodesis of the wrist. 
The active ROM 63° at the final follow-up was functionally satisfactory. Mean 
flexion was 29° representing 67% of preoperative flexion, and the extension was 
34°, representing 92% of the preoperative value. No deterioration in active ROM 
developed between 1 year and the final follow-up. The mean power grip was 17 kg 
pre-operatively and 20 kg at the final follow-up (p=0.288). Factors correlating with 
postoperative grip power were pre-operative grip power of the same hand (r=0.683), 
the post-operative grip power of the contralateral hand (r=0.906) and pain (r=-
0.570). 
Consolidation of the arthrodesis was seen in radiographs in all cases, and the 
correction of the dislocation was achieved in most of the wrists. The carpal ulnar 
distance ratio was 0.26 (SD 0.05) pre-operatively and 0.30 (SD 0.06) 
postoperatively, which indicates that correction of the ulnar translocation of the 
carpus was achieved (p=0.015). In 15 wrists out of 23 metacarpal angulations (the 
angle between the third metacarpal and the radius) was between 5° radial deviation 
and 10° ulnar deviation. In the frontal axis, the position of the lunate was neutral in 
16 wrists, and slight VISI deformity was found in four wrists and DISI in three 
wrists. As expected, impairment of flexion was greater than the average in DISI 
wrists. The ROM seemed to be best sustained in the neutral group, in which the 
postoperative ROM was 68° (84% of pre-operative ROM), compared to the 
postoperative ROM in the VISI group (52°, 63% of the preoperative ROM) or in the 
DISI group, in which the postoperative ROM was 55° and 72% of the pre-operative 
value. No statistical significance was seen between these small-sized groups. 
In addition to two cases with arthritis progression in the midcarpal joint leading 
to total arthrodesis, in eight wrists the midcarpal joint was narrowed and in five 
cases some bone destruction in the midcarpal joint was observed. The destruction 
degree of the midcarpal joint at the final follow-up did not affect ROM or grip 
strength, but correlated with pain and subjective results. 
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2. Clinical and radiological results of 
bioabsorbable 96L/4D poly-L/D-lactide 
copolymer implant in MCP arthroplasty 
 
2.1 Outcomes prior to material bioabsorption (Studies II 
and IV) 
96L/4D poly-L/D-lactide copolymer scaffold had open and interconnected porosity 
throughout the implant structure, and the calculated porosity of the scaffolds was 
approximately 80% (75-83%). Remaining tensile strength, in vitro in phosphate 
buffer saline (pH 7.4, temp 38°), was 50% at 12 weeks. 
Pain relief was achieved well. All patients reported relief from pain at follow-up 
in Study II, and median pain (VAS, 0-100) improved significantly, from 40 to 6, in 
Study IV. Active extension improved and flexion deteriorated, thus the arc of active 
ROM shifted towards extension in both studies. The average range of motion, 
obtained by pooling ROM data of individual fingers was 51° at follow-up in both 
studies, and preoperatively it was 46° in Study II and 41° in Study IV. The 
improvement in the power grip strength (from 9.4 kg to 11.7 kg) was statistically 
significant (p=0.016) in Study IV, but the change from 8.0 kg to 8.2 kg was not 
statistically significant (p=0.80) in Study II.  
In Study IV hand function was evaluated by ADL mimicking tasks in which 
MCP joints are involved. An improvement in these functional tests was observed 
except in the tip pinch grip of the index finger and in the precision grip (handling of 
the knife and fork).  Improved ability to eat and to take care of personal hygiene was 
observed in Study II. In the Box and Block dexterity test the results improved from 
preoperative 59 to postoperative 66 (p=0.001). Subjective satisfaction was excellent 
or good in 20 out of 27 patients in Study IV and in seven out of 15 patients in Study 
II.  
The correction of ulnar deviation was achieved well as it improved from 
preoperative mean 26° to postoperative mean 6° (p=0.001) in Study II, and from 
preoperative (MCPII-III-IV-V) 13-26-32-41 to postoperative 2-8-7-10 in Study IV. 
Palmar subluxation improved significantly in both studies. Palmar subluxation of 
more than half of the bone height was present in 56% of the MCP joints 
preoperatively and in 6% at follow-up in Study II. In Study IV preoperatively in the 
‘no palmar subluxation’ group there were nine joints and in the ‘dislocation’ group 
19 joints, and at follow-up 40 and six joints respectively.  
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2.2 Outcomes beyond the bioabsorption time (Study III) 
The clinical outcome of the study with longer follow-up did not differ substantially 
from the outcome of the studies performed with follow-up shorter than the 
bioabsorption time of the implant. Pain was alleviated in all 23 patients, and at final 
follow-up 13 patients were pain-free and 10 patients reported occasional pain. The 
mean extension deficit of the MCP joints improved from 32° preoperatively to 15° 
at final follow-up, and mean MCP flexion deteriorated from 76° to 63° respectively. 
The outcome of ROM was maintained between intermediate (14 months) and final 
follow-up (59 months). 
The ability to perform personal ADL (dressing, eating and personal hygiene) 
improved, but no effect was observed on the ability to work, study or carry out 
exercise and leisure activities. Pinch grip improved, but no significant changes were 
observed in the other grasps. Grip strength deteriorated in the hand operated on 
from preoperative median 6 kg to postoperative 4.5 kg (p=0.043), and in the hand 
not operated on from 8 kg to 6.5 kg (p=0.010). At intermediate follow-up grip 
strength median was 7 kg in the hand operated on and 9 kg in the non-operated 
hand, which may also have been influenced by postoperative intensive rehabilitation 
supervised by an occupational therapist. Patient satisfaction was excellent or good in 
12 out of 23 patients. 
The correction of the ulnar deviation was achieved and well sustained. The 
preoperative ulnar deviations were 14°, 22°, 28° and 37° for the index, middle, ring 
and little fingers, respectively. At intermediate follow-up the corresponding figures 
were 3°, 9°, 7° and 7° and at final follow-up 0°, 5°, 7° and 10°. Palmar subluxation 
exceeded half of the bone thickness in 39 out of 80 joints before surgery and in nine 
joints (out of 80) at final follow-up, and  in 71 joints (89%) the palmar subluxation 
was less than half of the bone thickness at the final follow-up and in 27 (34%) joints 
palmar subluxation did not occur at all. Some statistically insignificant tendency of 
progression in palmar subluxation was observed between the intermediate and the 
final follow-up visits.  
Osteolytic changes were minor and confined to joint surface areas, but were not 
found in the diaphyseal bone. Osteolytic changes exceeding 2 mm had developed on 
the surfaces of the metacarpal and/or proximal phalangeal bone surfaces in three out 
of 80 cases between 3-month and final follow-up. In conclusion, implant absorption 
did not induce any significant osteolysis. None of the implants had to be revised. 
 
 
 
3. Outcome of 96L/4D poly-L/D-lactide 
copolymer implant compared to Swanson 
silicone prosthesis (Study IV) 
 
The clinical outcomes of MCP joint arthroplasty using 96L/4D poly-L/D-lactide 
copolymer implant or Swanson silicone implant were quite similar at a mean of 24 
months of follow-up. Median pain decreased significantly from preoperative 37 
(VAS, 0-100) to 5 in the Swanson group, and from 40 to 6 in the PLDLA group. 
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Active extension improved and flexion deteriorated equally in both groups, except 
flexion of the IV MCP joint, which deteriorated less in the Swanson group, from 77° 
to 73° (p=0.304) than in the PLDLA group, from 79° to 65° (p<0.001) (Table 4).  
Functional grip assessments improved on preoperative values except precision 
grip and transverse volar grip in the PLDLA group. However, no statistically 
significant differences were observed in postoperative functional grip assessments 
between the Swanson and PLDLA groups. The Box and Block dexterity test 
improved in the PLDLA group (from 59 to 66, p=0.001), whereas the change from 
60 to 64 in the Swanson group was not statistically significant (p=0.136). No 
difference was observed in outcome of power grip strength between the Swanson 
and PLDLA groups. In the Swanson group power grip improved from 9.7 kg to 11.4 
kg (p=0.01) and in the PLDLA group from 9.4 kg to 11.7 kg (p=0.016). Patient 
satisfaction at follow-up was similar in the Swanson and PLDLA groups. Subjective 
outcome was excellent or good in 17 patients in the Swanson group and in 20 
patients in the PLDLA group.  
A significant and comparable improvement was achieved in ulnar drift correction 
in the Swanson and PLDLA group. In the Swanson group ulnar deviations at 
follow-up were 3°, 5°, 5° and 6° in the index, middle, ring and little fingers, 
respectively, and in the PLDLA group 2°,8°,7° and 10°, with no difference between 
the groups pre- or postoperatively (Table 4).  
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Table 4.Active range of motion (degrees) and ulnar deviation (degrees) in Swanson and PLDLA 
arthroplasty groups before operation and at the follow-up (mean 24 months after surgery) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 A comparison before vs. after Swanson artrhroplasty 
2
 A comparison before vs. after PLDLA arthroplasty 
3
 A comparison of preoperative values between Swanson and PLDLA  
4
 A comparison of follow-up values between Swanson and PLDLA  
 Swanson   PLDLA     
 Preoperative Follow-up p-
value1 
Preoperative Follow-up p-
value2 
p-
value3 
p-
value4 
Extension 
lack 
        
MCP II 25 15 0.001 27 16 0.001 0.615 0.664 
MCP III 33 17 <0.001 37 22 <0.001 0.548 0.238 
MCP IV 29 15 0.012 40 17 <0.001 0.147 0.760 
MCP V 32 14 0.001 31 8 <0.001 0.902 0.225 
Flexion         
MCP II 75 67 <0.001 73 66 0.009 0.669 0.752 
MCP III 82 72 <0.001 81 71 <0.001 0.789 0.736 
MCP IV 77 73 0.304 79 65 <0.001 0.743 0.031 
MCP V 77 66 0.005 73 58 0.002 0.405 0.203 
Ulnar 
deviation 
        
MCP II 12 3 0.004 13 2 0.001 0.704 0.506 
MCP III 21 5 <0.001 26 8 <0.001 0.244 0.186 
MCP IV 26 5 <0.001 32 7 <0.001 0.403 0.507 
MCP V 34 6 <0.001 41 10 <0.001 0.385 0.263 
 
 
Palmar subluxation improved significantly in both groups, but at follow-up 
palmar dislocation was observed more frequently in the PLDLA group (44 joints) 
than in the Swanson group (10 joints). The recurrence of palmar subluxation was 
less than the height of the metacarpal bone in 38 out of 44 joints in the PLDLA 
group, and in 10 out of 10 joints in the Swanson group (Table 5). Twelve (10 %) 
Swanson implants were broken in radiological analysis at follow-up. In addition, 
perforation of the phalangeal cortex was noted in two fingers.  
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Table 5.    Palmar subluxation in Swanson and PLDLA arthroplasty before operation and at the follow-up (mean 24 months after surgery) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A=no palmar subluxation   B=palmar subluxation C=luxation 
 
1
 A comparison before vs. after Swanson artrhroplasty 
2
 A comparison before vs. after PLDLA arthroplasty 
3
 A comparison of preoperative values between Swanson and PLDLA  
4
 A comparison of follow-up values between Swanson and PLDLA  
 Swanson PLDLA     
 Preoperative Follow-up p-value1 Preoperative Follow-up p-value2 p-value3 p-value4 
 
A B C A B C  A B C A B C    
MCP II 4 17 4 21 4 0 <0.001 0 18 5 9 12 2 0.008 0.164 0.001 
MCP III 4 17 4 22 3 0 <0.001 2 16 4 7 13 2 0.038 0.578 <0.001 
MCP IV 8 8 5 19 2 0 0.001 3 12 4 13 5 1 0.001 0.368 0.079 
MCP V 6 7 7 19 1 0 0.001 4 10 6 11 8 1 0.003 0.862 0.004 
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DISCUSSION 
 
 
 
1. Radiocarpal partial arthrodesis in 
rheumatoid hand surgery 
 
In this thesis the results of subjective satisfaction and pain after partial radiocarpal 
arthrodesis were comparable to those of earlier studies in rheumatoid patients 
(Stanley, 1989; Doets & Raven, 1999; Borisch & Haussmann, 2002; Ishikawa et al., 
2005).  When ROM has been used as the outcome measure, wide variation has been 
reported. A decrease of wrist motion in all directions or only of wrist flexion has 
commonly been described (Ishikawa et al., 1992; Borisch & Haussmann, 2002; 
Ishikawa et al., 2005). Postoperative ROM in our study (63°) is slightly better than 
on average in earlier publications. This is due at least in part to patient selection; in 
our study none of the cases were advanced Larsen IV stage patients. Overall the 
ROM after partial radiocarpal fusion is wide enough to enable ADL tasks according 
to biomechanical studies (Brumfield & Champoux, 1984; Ryu, Cooney, Askew, An, 
& Chao, 1991). Despite pain alleviation, correction of the malalignment and 
stability of the wrist, the effect of radiocarpal fusion on grip power is not clear. The 
evaluation of grips in the rheumatoid hand is in general challenging, because it 
changes depending on the state of the joints of the whole hand.  
Radiocarpal arthrodesis enables repositioning of the ulnar translocation and 
palmar subluxation of the rheumatoid wrist, and the corrected position was 
maintained in this study as in the long-term study study with 13 years of follow-up 
by Ishikawa et al. (2005). The effect of the radiocarpal fusion on ulnar drift in the 
rheumatoid hand has not been established, but malalignment of the wrist joint seems 
to aggravate the ulnar shift of the metacarpophalangeal joints (DiBenedetto, 
Lubbers, & Coleman, 1991; van Vugt et al., 1999), and the reconstructive surgery of 
MCP joints has commonly been reported to be shortlived in cases with wrist 
malposition (Burke, 2011).   
The main problem after radiocarpal fusion is the radiological progression of 
midcarpal joint destruction, which has on average been observed already at-two year 
follow-up in many studies (Linscheid & Dobyns, 1985; Stanley, 1989; Ishikawa et 
al., 1992). Ishikawa et al. (2005) reported midcarpal destruction in 36% of cases at 
mean 13-year follow-up, whereas in the study by Borisch and Haussmann (2002) at 
five-year follow-up destruction of the midcarpal joint was observed in 73% of the 
wrists. Borisch and Haussmann (2002) stretched the indications further than other 
authors; 44% of their cases being Larsen grade IV. In our study including only 
Larsen II and III cases midcarpal destruction was observed in 57% of cases at mean 
5.8 years after surgery, and the changes did not affect ROM, but pain and subjective 
satisfaction were inferior to cases in which the midcarpal joint was well preserved. 
Destruction in the midcarpal joint appears to be less symptomatic and better 
tolerated than destruction in the radiocarpal joint, probably because the midcarpal 
joint has greater intrinsic stability (Doets & Raven, 1999; Arimitsu et al., 2007).   
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The literature on radiocarpal arthrodesis is not extensive, but the reported 
variation in the results is wide. Differences in patient selection and in the indications 
are one reason for this, but in addition the radiocarpal arthrodesis operation is prone 
to technical errors. However, this study, together with the earlier literature, shows 
that radiocarpal arthrodesis provides a satisfactory outcome if the arthritic 
destruction is limited to the radiocarpal area and the rheumatic disease itself is under 
control. It preserves the mobility and bone stock of the wrist, and the survival seems 
to be better than in joint replacement surgery with today’s implants. Either total 
arthrodesis or arthroplasty can be performed without any problems after partial 
radiocarpal arthrodesis if further progression occurs.  
 
 
 
2. 96L/4D poly-L/D-lactide copolymer 
implant in MCP arthroplasty 
 
MCP joint deformity is responsible for the greater part of the impairment of the 
aesthetics in rheumatoid hand, and also substantially inhibits hand function. This 
deformity in its advanced stages consists of cartilage and/or bone destruction and 
soft tissue imbalance, thus, in addition to the joint replacement, soft tissue balancing 
is also necessary in its surgical treatment. The problems associated with the use of 
the gold standard silicone MCP implant, such as fractures of the implant, 
periprosthetic bone osteolysis, deterioration of the outcome and technical difficulties 
in revision surgery, have led to development work to invent alternative implants. 
Aseptic loosening problems often occurring with metallic and other inelastic 
implants, especially in the rheumatoid hand, directed the product development in 
our team to materials with better biocompatibility with soft rheumatic bone. The 
bioabsorbable 96L/4D poly-L/D-lactide copolymer, which has been used in 
orthopaedic devices available on the market since 1999, was chosen as the raw 
material. The manufacturing process was developed with the aim of creating an 
implant with desirable mechanical properties associated with an optimal degradation 
rate, and enabling ingrowth of host tissue into the device. 
In the preliminary studies (II and III) no serious adverse events were reported, 
and the clinical outcome was comparable with the results of silicone arthroplasty in 
the literature, although 63% of the joints operated  on were Larsen IV and V, and 
although the material included a large number of revision arthroplasties (over 30% 
of the joints operated on). Active extension improved and flexion deteriorated, 
which also has been a typical finding after MCP silicone arthroplasties. Transferring 
the arc of ROM towards extension improves the ability to grip larger objects. 
Improvement in the ability to perform personal ADL (dressing, eating and personal 
hygiene) was also assessed. The postoperative ranges of motions (from 46° to 51°) 
are slightly above the average ROMs after silicone MCP arthroplasty as reported in 
the literature. Correction of ulnar drift and palmar subluxation were achieved, and 
well maintained, also beyond the resorption time of the implant. However, a 
statistically insignificant tendency of progression in palmar subluxation was 
observed between intermediate and final follow-up. An important aspect disclosed 
by these studies was that no adverse tissue reactions occurred, either in the phase of 
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mechanical strength loss or in the monomer elimination phase. Osteolytic changes 
were minimal, on average 59 months after surgery in 4% of cases over 2 mm 
resorption was measured, and never exceeded 4 mm. This indicates indirectly that 
the degradation rate and volume of the implant were on a par with the clearing 
capacity of the tissue.  
Compared to the Swanson prosthesis a fairly similar outcome was observed on 
average two years after surgery. Improvement was observed in lack of extension, 
pain, ulnar drift, power grip and functional grips, and no statistically significant 
differences were seen in postoperative values between the PLDLA and Swanson 
groups. Palmar subluxation improved significantly in both groups, but in the 
PLDLA group there was a tendency of the volar subluxation to recur. In the 
Swanson group no palmar subluxation was seen in 82% of joints at follow-up, 
whereas only 48% of joints were in proper alignment in the PLDLA group. 
Although the palmar subluxation was mainly partial and only 7% of the joints were 
totally dislocated, the maintenance of palmar alignment in the PLDLA group was 
not as good as in the Swanson group. Assessments of palmar subluxation have not 
been reported in the literature of silicone MCP arthroplasties, whereas the 
recurrence of the ulnar drift has been a common finding. The problem is the 
inaccuracy of the evaluation of the palmar subluxation. Clinical assessment by 
inspection and palpation is unreliable and radiological assessment is heavily 
dependent on the quality and standardisation of the X-rays. The implications of the 
recurrence of palmar subluxation for the outcome of MCP arthroplasty are 
uncertain. Theoretically palmar subluxation impairs extension, but in this study lack 
of extension at follow-up in the PLDLA group was similar to that in the Swanson 
group. The recurrence of palmar displacement was partial, which may explain the 
good extension. The motion of the joint along the implant axis, for which the exact 
alignment of the joint is necessary, is important for the survival of biostable 
prostheses, but when bioabsorbable implants are used implant fracture is not an 
issue. However, in the long run palmar subluxation probably disturbs the sensitive 
tendon balance of the fingers. 
Implant fracture and related problems do not occur when PLDLA bioabsorbable 
implants are used, thus the patients can be allowed to carry heavy objects. Bone 
osteolysis seems to be rare at the midterm follow-up (4%), and is restricted to joint 
surface area and does not occur in the diaphyseal area. A stemless PLDLA implant 
enables bone grafting into the intramedullary canals in revision surgery, which is 
one of the distinct advantages of this implant. The correction of ulnar drift was 
maintained well in all studies. 
 
 
 
3. Methodological considerations 
 
The data in all studies in the present thesis was collected prospectively but only one 
study (IV) was a randomised clinical trial, and no control groups were included in 
the other studies. The randomised study was not double-blinded. The investigators 
also operated on patients and took care of postoperative controls seeing the chosen 
implant in the operation and in the x-rays. Small sample size was a weakness in 
Studies I, II and III. Partial arthrodesis of the wrist (Study I) is a relatively 
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infrequent operation, which limits patient recruitment. The significance of the 
results is diminished by the small sample sizes; especially in subgroup analyses such 
as those in Study I. Limited material is explicable in the implementation of the novel 
device in Studies II and III, in which the short-term biocompatibility and mid-term 
clinical outcome of the 96L/4D poly-L/D-lactide copolymer implant were studied.  
In the world of science these descriptive and observational studies are obviously not 
ranked as highly as randomised double-blinded studies, but in the literature on 
rheumatoid hand surgery randomised clinical trials are rare. 
Radiological measurements are prone to inaccuracy due to the variation in x-ray 
projections, especially when the findings are minor, as in the examination of bone 
erosions and osteolysis in this study. In Studies I-III the x-rays were taken in the 
same unit and education of the projections was provided before the study to improve 
repeatability. A cradle was used to enhance the standardisation of the supine oblique 
projection of the hand.  
 
 
 
4. Future considerations 
 
The conservative treatment of rheumatoid arthritis has improved significantly in 
recent years, which presumably inhibits the arthritic progression of the midcarpal 
joint after partial radiocarpal arthrodesis. Active and close co-operation between 
rheumatologists and surgeons, which improves the timing of surgical interventions, 
should be strengthened. Partial wrist arthrodesis is a typical example of an operation 
with a limited “time window” for its performance, but compared to the gold 
standard total arthrodesis operation it preserves the motion of the wrist joint. The 
variation in the outcome after partial wrist arthrodesis in the treatment of the 
rheumatoid hand partly reflects the technical demands of the operation. The results 
of a technically demanding operation can be improved by cumulative experience 
based on increasing volumes of operations performed by a single surgeon, which in 
relatively infrequent operations means that some specialisation and centralisation 
are useful.  
In this thesis the outcome of the novel 96L/4D poly-L/D-lactide copolymer 
implant in the treatment of rheumatoid hand MCP joints is overall comparable with 
that of the gold standard silicone prosthesis, and due to recently acquired CE 
marking wider clinical experience can be gathered. A higher volar subluxation 
tendency in the PLDLA group compared to the Swanson group was seen in the 
randomised study (IV), and this must be followed and studied more closely, 
especially beyond the resorption time of the implant. The degradation of scaffolds 
can be tailored by material technical actions, for example changing polymer and 
fibre processing conditions (Paakinaho, Ellä, Syrjälä, & Kellomäki, 2009). The 
design with polyethylene oxide and polybutylene terephtalate stems did not yield on 
improvement, because major osteolysis and inflammatory foreign-body reaction 
were reported in the experimental study in minipigs (Waris, Ashammakhi, 
Lehtimaki, Tulamo, Tormala, Kellomaki, & Konttinen, 2008). In addition to the 
development work of implant design, the enhancement of the balancing technique of 
the soft tissues may reduce the tendency of volar subluxation.  
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Rheumatoid arthritis patients present in increasingly better condition and have a 
more active lifestyle due to effective medical treatment, which may also imply more 
powerful use of hands operated on and greater loads on the silicone MCP joints. The 
need for longlasting implants with less bone reaction in more active patients is also 
evident. Active basic and clinical research work is needed to find suitable materials 
and designs for the implants for this small market.   
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SUMMARY AND CONCLUSIONS 
 
 
1. Partial radiocarpal arthrodesis in surgery of the rheumatoid wrist in 
Larsen II-III stages yields good pain relief and subjective satisfaction and 
preserves the functional range of motion of the joint. Ulnar translocation 
malalignment can be corrected and maintained.  
2. MCP joint arthroplasty with the novel bioabsorbable 96L/4D poly-L/D-
lactide copolymer implant enables correction of ulnar drift, relieves pain 
and restores the arc of motion towards extension.   
3. Clinical results beyond the resorption time of the 96L/4D poly-L/D-
lactide copolymer implant were sustained and comparable with earlier 
silicone arthroplasty results. Osteolytic changes were minimal at average 
59 months of follow-up. 
4. The subjective and objective outcomes of bioabsorbable 96L/4D poly-
L/D-lactide copolymer arthroplasty were comparable to those of 
Swanson arthroplasty except for more frequent recurrence of palmar 
subluxation in the PLDLA group.  
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INTRODUCTION
THE ARTHRITIC DESTRUCTION of metacarpophalangeal(MCP) joints in rheumatoid arthritis (RA) typically
leads to ulnar deviation and volar subluxation of the fin-
gers, which greatly impairs the function of the hand, es-
pecially the ability to grasp objects of large size (Fig. 1).1
The MCP joint, with its complex musculotendinous sys-
tem, its unusual mobility and stability, and its large ap-
plied stresses, has proved to be a difficult challenge in
joint replacement design. The nonprosthetic tendon and
volar plate interposition artrhoplasties are of historic in-
terest, and continue to have occasional usage.1 The pros-
thetic arthroplasty of MCP joints of the fingers was be-
gun with metallic devices in the 1950s.2 A large number
of nonmetallic materials including pyrolytic carbon, ce-
ramics, and ultrahigh molecular weight polyethylene
have been used to manufacture MCP joint prosthesis.3,4
The reports of those studies include several complica-
tions: bone resorption, prosthesis migration, infections,
foreign body reactions, and prosthesis dismantling.3,4 It
was in the late 1960s that silicone devices were devel-
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ABSTRACT
Swanson silicone implant is the “gold standard” of metacarpophalangeal joint reconstruction in
rheumatoid arthritis (RA) patients. However, durability problems of silicone implants have led us
to develop a new technique based on bioreconstructive implants. PLA96 (poly-L,D-lactide copoly-
mer, L:D ratio of 96:4) scaffolds were engineered. Bioabsorption and substitution of porous PLA96
scaffold with living tissue eventually produce a neojoint. In the current prospective study, 23 RA
patients (80 joints) were operated on, using PLA96 implants. Fifteen patients (54 joints) have been
monitored for at least 1 year. Pain alleviation was well achieved. Range of motion improvement was
emphasized to extension direction of functional arc. The average ulnar deviation was preoperatively
26°, and at follow-up it was 6°. Volar subluxation was noticeable in 56% of joints preoperatively
and in 6% at 1-year follow-up. This is the first report of the formation of a living, functional joint
in situ by means of a synthetic bioreconstructive joint scaffold. Results of this preliminary short-
term study are comparable with previously published data on silicone arthroplasty. However, biore-
constructive prostheses can aid in preventing problems that occur with biostable prostheses. Tissue
engineering has created a new era in the reconstruction of damaged joints.
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oped and the concept of prosthetic replacement of MCP
joints became widely accepted and applied.2
A one-piece silicone implant with stems and a spacer
in the middle is most commonly used for the recon-
struction of MCP joints in RA patients. In the operation
the stems of the implant are placed in the bone cavities
of metacarpus and proximal phalanx. The spacer sets be-
tween the bone ends and acts as a joint spacer during the
encapsulation process, when the body forms a fibrous
capsule around the implant.5 The most used and best doc-
umented implant is the so-called Swanson prosthesis.
Breakage of the implants has been a common problem
in silicone arthroplasty series. Depending on the length
of the follow-up period and study methods used, a range
of 5–82% prevalence has been reported in different stud-
ies.6 Particles released from either intact or broken pros-
thesis cause tissue reactions such as foreign body granu-
lation in the joint and around the prosthesis inducing
osteolysis.7,8 Resorption of the bone due to the implant
or progressive disease can make reoperation using
stemmed prosthesis difficult or even impossible to per-
form. Especially in such cases an implant without stems
would be preferable because it enables intramedullary
bone grafting.
In clinical work patients with one or more previous sil-
icone arthroplasties with prominent ulnar deviation and
volar subluxation of the fingers due to breakage of the
implant are commonly met. Usually in these cases sili-
cone arthroplasty is not possible to perform because of
insufficient bone stock, as discussed above. Some sal-
vage operation should be offered for the patient to main-
tain his or her ability to perform daily activities.
HONKANEN ET AL.
The principle of in vivo tissue engineering, meaning
that a porous scaffold is implanted in situ and filled with
in-grown tissue, thus forming a living, functional tissue
or organ, was applied in studies preceding current ex-
periments. In 1994 the concept of the bioreconstructive
joint scaffold was developed in our group by performing
a first prospective study using commercially available
bioabsorbable Vicryl and Ethisorb fleeces folded into
small, rectangular scaffolds.9 The innovation for the ex-
periment was the so-called Vainio method, in which the
extensor tendon is folded between the ends of the
metacarpus and phalanx. The tendon creates a sliding sur-
face between the bone ends and acts as a counterforce to
volar subluxation tendency.10
The folded scaffold was intended to behave in a sim-
ilar way as the tendon. However, the resorption time of
both tested materials was too short. The tissue did not
have enough time to regenerate and mature, and the joint
space collapsed. The principal idea of the scaffold, how-
ever, proved to be clinically successful and a scaffold
consisting of a porous bioabsorbable poly-L,D-lactide
copolymer with an L:D monomer ratio of 96:4 (PLA96)
with longer absorption time was designed. The scaffold
is intended to be a temporary support and to be filled in
by the ingrowing tissue of the host and later to be com-
pletely replaced by new living tissue. Thus it can be used
to reconstruct a functional joint and the patient can use
the hand better than preoperatively. The preceding in
vitro experiments have shown that the filaments retain at
least 50% of their tensile strength for 13 weeks (phos-
phate-buffered saline [PBS], pH 7.4, 37°C), and scaffolds
retain their shape for at least the same amount of time.11
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FIG. 1. Preoperative photograph of the rheumatoid hand with typical volar subluxation and ulnar deviation of the fingers. Pic-
ture has been taken with maximum active extension.
Compared with the complete loss of tensile strength of
Ethisorb fibers in vivo in 4 weeks (our unpublished re-
sults) the strength retention is remarkably longer. The
50% strength retention in 13 weeks has been estimated
as minimum strength retention time to keep up the joint
space long enough for tissue maturation. In animal tests,
connective tissue ingrowth into the mesh structure has
been observed after the first week,12 PLA96 scaffolds im-
planted in rat subcutis were filled with tissue in 3
weeks,13 and self-reinforced PLA96 copolymer rods were
totally absorbed within 3 years.14
The purpose of the present study was to evaluate the
clinical, radiological, and functional outcomes of PLA96
joint scaffold arthroplasty in severe arthritic destruction
and revision operation after failure of silicone arthro-
plasties in the metacarpophalangeal joints of RA patients.
MATERIALS AND METHODS
Scaffolds
Polymer used in this study was medical-grade and
highly purified (residual monomer content, 0.1%, ac-
cording to the manufacturer) polylactide L- and D-copoly-
mer with an L:D monomer ratio of 96:4 (PLA96; Purac
Biochem, Gorinchem, The Netherlands). Intrinsic vis-
cosity, i.v., (chloroform, 25°C) was 6.8 dL/g and heat of
fusion (value corresponding to crystallinity) was 40.1 J/g
(both according to manufacturer). Before processing, the
polymer was predried.
Four-ply multifilament yarn was melt-spun from
PLA96, using an Axon BX-15 single screw extruder
(screw diameter 15 mm; ratio of screw length to diame-
ter 24; Axon, Åstorp, Sweden) with a spinneret with four
orifices (each with a diameter of 0.5 mm). The lowest
barrel temperature was 158°C and the die temperature
was 260°C. The yarn was oriented by drawing it freely
in a two-step process to a draw ratio of about 4.5.
The yarn was knitted to a tubular mesh, using a tubu-
lar single jersey knitting machine (Textilmaschinenfab-
rik Harry Lucas, Neumünster, Germany). The knitted
tube was rolled to cylindrical scaffolds and heat-treated
above glass transition temperature (Tg) of polymer in the
molds. All the samples were packed and sterilized by g
irradiation before use.
Methods for yarns and scaffolds
All the yarns (four-ply multifilaments) were incubated
in PBS (pH 7.4, 37°C) for periods of 1, 2, 4, 6, 8, 10, 13,
16, and 19 weeks. The solutions were changed regularly
every two weeks and the buffer capacity of the solution
was checked by pH measurements. Before testing, all the
samples were rinsed with deionized water.
The yarns were tested at a cross-head speed of 30
BIORECONSTRUCTIVE JOINT SCAFFOLD
mm/min, using an Instron 4411 materials testing machine
(Instron, High Wycombe, UK). Pneumatic grips were
used, and the gauge length was 100 mm. Initial tensile
results were measured on dry specimens, and after in vitro
hydrolysis wet specimens were tested. Mean and stan-
dard deviations of stress and strain at maximum load were
calculated (n 5 10).
Porosity of the scaffolds was calculated by determin-
ing the weight and size of the scaffolds and calculating
against the solid piece of PLA96.
Pore size measurements were done for g-sterilized
samples. Scaffolds were fixed in epoxy resin. Fixed scaf-
folds were cut into three sections both in height and in
diameter planes and surfaces were polished. Thirty ran-
domly chosen distances between the fibrils in the yarns
(small pores) and between the yarns (large pores) were
measured on the basis of optical microscopy images of
each section. Measured values were multiplied by 1.6 to
estimate round pores.
Patients
Twenty-three rheumatoid arthritis (RA) patients with,
altogether, 80 operated metacarpophalangeal (MCP)
joints were operated on, using PLA96 scaffolds. All pa-
tients were informed of the study protocol and asked to
participate. Clinical use of the new interposition joint
scaffold prosthesis was confirmed by permission of the
Ethics Committee of the Tampere University Hospital
and Pirkanmaa Hospital District (Tampere, Finland).
During the study 15 patients and their 54 joints reached
the follow-up stage of 1 year and the outcome is reported
in this study. Average follow-up is 1 year and 8 months
(12–27 months). There were 13 women and 2 men; the
mean age of the patients at the time of operation was
546 13 (range, 37–78) years. The mean duration of
rheumatoid arthritic diagnosis was 176 8 (range, 7–41)
years. The preoperative mean value of C-reactive protein
in patients was 216 12 (range, 8–39) and the sedimen-
tation rate was 156 13 (range, 4–40). Eight patients were
using cytotoxic medication and 13 patients received glu-
cocorticoid medication at the time of operation. The av-
erage time of cytotoxic medication usage was 5.96 3.7
(range, 0.5–11) years and that of glucocorticoid medica-
tion was 9.56 4.7 (range, 0.5–15) years. The MCP joint
of the index finger (MCP II) was operated on in all 15
patients, the MCP joint of the middle finger (MCP III)
in 14 patients, MCP IV in 12 patients, and MCP V in 13
patients. The preoperative radiological destruction stage
of the operated joints, according to Larsen (scale, I–V),15
was stage III in 2 of the operated joints (4%), stage IV
in 21 joints (39%), and stage V in 13 joints (24%). Stage
V presents the most severe destruction of the joint. Pre-
vious silicone arthroplasty had been performed for 6
(40%) patients and thus in 18 (33%) joints.
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Surgical technique and rehabilitation
Operations were performed with a tourniquet (100
mmHg above systolic blood pressure). Preoperative pro-
phylactic antibiotic (cefuroxime) was used. In the oper-
ation resection of the bone was equal to Swanson arthro-
plasty. The quantity and quality of soft tissue balancing
in the operation were determined by grade and type of
deformity. When ulnar deviation existed, the proximal
bony attachments of both collateral ligaments were re-
leased. Deliberation of the volar capsule under meta-
carpal bone and release of the volar plate were performed
to achieve adequate correction of volar subluxation. Ul-
nar intrinsic muscle contractures were released when re-
quired. The abductor digiti minimi of the fifth finger was
always dissected. The PLA96 scaffold was fixed with re-
sorbable sutures through the metacarpal bone via the
volar plate.
Intramedullary bone grafting was performed in revi-
sion arthroplasties. Balancing and tightening of the col-
lateral ligaments were performed by duplicating or re-
fixing the ligament more proximally through drill holes
in the proximal metacarpal bone. At the end, the exten-
sor tendon was centralized.
In rehabilitation, the operated MCP joints were sup-
ported with a volar static splint during the first 10 days
after operation. Active and passive range of movement
exercises were assisted with a low-profile dynamic dor-
sal splinting starting 10 days postoperatively and contin-
ued up to 12 weeks. Light activities of daily living (ADL),
like eating and personal hygiene, were allowed immedi-
ately after dynamic splint initialization. The rehabilita-
tion was controlled by an occupational therapist.
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Methods for patient examination
The clinical, radiological, and functional assessments
were carried out preoperatively and at follow-up (3
months and 1 and 2 years after surgery). Fifteen patients
(54 joints) were monitored for at least 1 year. The mean
follow-up time in this prospective study was 1 year and
8 months, with a range of 12 months to 2 years and 3
months. Functional measurements and interviews were
performed by the same occupational therapist. Volar sub-
luxation (sliding of the proximal phalange in the palmar
direction) and joint space were measured from volar
oblique radiographs. Subjective pain was evaluated with
a verbal rating scale. Active flexion, lack of active ex-
tension, and ulnar deviation (proximal phalange deflec-
tion to the lateral side) were measured clinically from a
dorsal aspect according to the standards of the American
Academy of Orthopaedic Surgeons.16 Grip strength was
measured with a Jamar dynamometer (handle position 2)
and according to the standards of the American Society
of Hand Therapists.17 The mean value of three grip
strength measurements was considered.
Results are presented as mean, range, standard devia-
tion, and proportion. Statistical analysis of mean values
was made using paired sample t test. In comparing clas-
sified variables pre- and postoperatively the measure used
was either k (for 2 3 2 tables), or g (for m 3 n tables, m
or n . 2) statistics. In the case of k and g a value near
0 corresponds to discordance between the variables in-
volved (e.g., lack of correlation between two variables).
A g value between 0.4 and 0.7 indicates a moderate con-
cordance, and a value. 0.7 great concordance, between
the variables. A k value, 0.20 means poor, 0.21–0.40
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FIG. 2. Remaining tensile strength (%) of PLA96 yarn plotted against weeks in vitro.
fair, 0.41–0.60 moderate, 0.61–0.80 good, and 0.81–1.00
very good concordance. A good congruence between pre-
and postoperative values means lower effectiveness of
the operation.
RESULTS
Yarns and scaffolds
Diameter of single filament varied between 70 and 80
mm. Processing and g irradiation decreased the intrinsic
viscosity of PLA96 to 1.28 dL/g. Initial tensile strength
of the g-sterilized yarns was 3456 40.7 MPa and strain
at maximum load was 31 6 3.1%. Within 19 weeks in
vitro the tensile strength of the yarn had dropped to 816
11.0 MPa, that is, 23% of initial strength (Fig. 2).
A typical scaffold is shown in Fig. 3. Calculated poros-
ity of the scaffolds was approximately 80% (varied from
75 to 83%). Scaffolds had open and highly interconnected
porosity throughout the structure, because the porosity is
formed by mesh loops and by layers of the mesh. Gen-
erally, pores can be divided into small pores, meaning
spaces between the filaments in yarn, and large pores,
consisting of pores inside and between the loops. The av-
erage diameter of the small pores was 86 mm and the av-
erage diameter of the large pores was 547 mm. In prac-
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tice, scaffolds have pores ranging from tens of microm-
eters up to 1 mm, because of the structure.
Clinical results
All patients reported relief from pain at the follow-up
of 1 year and 8 months (12–27 months) (Table 1). The
range of motion (ROM) improved from a nonfunctional
arc of flexion to a more functional arc of extension (Table
2). Preoperatively, the mean ROM of operated joints was
46°, and postoperatively it was 51°. The ROM did not
decrease in any of the patients during follow-up. The
functional results presented in Table 3 show that patients
were able to handle daily activities better than preopera-
tively.
Volar subluxation of more than half of the bone height
was present in 30 joints (56%) preoperatively and in 3
joints (6%) at follow-up (Table 4). Preoperatively, the
average ulnar deviation of operated joints was 26 6 18°
(range, 3–51°), and at follow-up it was 6 6 7° (3–30°)
(p , 0.001). The strength of the grip was sustained. Pre-
operatively, the measurement was 8.0 kg (mean) and
postoperatively 8.2 kg (mean), respectively (p 5 0.80).
At follow-up the mean joint space measured from X-rays
was 2.46 1.6 (range, 0–6 mm).
The cosmetic appearance was good; no swelling or fis-
tula formation was observed at the follow-up (Fig. 4).
The subjective satisfaction preoperatively was poor in 10
patients and tolerable in 5 patients. Postoperative sub-
jective satisfaction was excellent or good in seven pa-
tients, satisfactory in seven patients. There was one pa-
tient with poor subjective outcome, and this patient had
a humerus fracture with partial radialis paresis 1 year and
2 months after MCP arthroplasty. The fractured humerus
may have influenced the overall welfare of the patient.
DISCUSSION
Most of the more recent small joint surgeries have been
done with biostable joint prostheses, generally Swanson
prostheses. A tissue-engineering approach to create new
tissue formation in the joint cavity to form a functional
neojoint has not been reported previously. Thus, the
bioreconstructive MCP joint scaffold prosthesis is a new
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TABLE 1. PAIN PREOPERATIVELY AND AT FOLLOW-UPa
Mild pain Severe pain Severe pain
No pain in daily activities in daily activities at rest
Preoperatively 5 8 1 1
Postoperatively 10 5 0 0
g 5 0.71
aNumber of patients.
FIG. 3. The PLA96 joint scaffold implant.
concept in joint replacement surgery and the results of
this short-term study suggest that it may be possible to
treat joints in this way.
The function of scaffolds in this particular indication
is to create and maintain a space between the bone ends.
The surrounding tissue preferably invades the pores of
the scaffold and fills in the empty space. The tissue will
later function as a neojoint. The scaffold is porous, hav-
ing all pore sizes from some tens of micrometers in di-
ameter to more than 1 mm in diameter. Most probably
the pores are smaller in situ because of the compression
caused by bones and ligaments. Filling in the scaffold
with tissue probably occurs, because in follow-up radio-
graphs an empty space is seen where the implant was
placed. At that time the scaffold has already degraded to
such an extent that it no longer withstands applied loads.
The first 10 days in static splint allow undisturbed
growth of tissue into the scaffolds. By that time the scaf-
fold is relatively well filled with tissue, because tissue
ingrowth had occurred completely in 3 weeks in subcu-
taneous tissue in rats.13 At the 3-month follow-up time
the dynamic splint was removed from the patients and
tissue had probably filled in the scaffold completely. By
the 1-year follow-up time, the yarns of the scaffold carry
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no load, because of degradation, but they still may sup-
port the joint cavity. The empty space seen in radiographs
where the scaffold had been placed is at that time most
probably a combination of the patient’s own tissue and
remainders of the PLA96 scaffold.
Although all the operated joints were extensively de-
stroyed by RA and the current material included a great
number of revision arthroplasties (40% of the patients
and 33% of the operated joints), which are in most cases
impossible to treat by any other method, the results are
promising and functionality of the hands was at least
comparable to those previously reported for silicone
arthroplasties.6
ROM improved slightly and was broad enough. It is
important that the ROM was postoperatively at a good
level in the extension–flexion arc for hand function,
which enables the patient to grip larger objects. This was
seen as improved ability to perform daily activities, such
as eating and taking care of personal hygiene. Correction
of rheumatic deformations, volar subluxation, and ulnar
deviation was achieved and well preserved at least over
12–27 months of follow-up. According to animal and in
vitro studies most of the PLA material degrades in this
time. Individual results had not deteriorated during this
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TABLE 2. RANGE OF MOTIONa
MCP II MCP III MCP IV MCP V All operated joints
Active flexion
Preoperatively 72 76 80 73 75
Postoperatively 68 75 68 62 69
p 5 0.06 p 5 0.4 p 5 0.0001 p 5 0.029
Active extension lack
Preoperatively 25 28 34 29 29
Postoperatively 19 23 17 13 18
p 5 0.15 p 5 0.22 p 5 0.01 p 5 0.06
Abbreviations: MCP II, index finger metacarpophalangeal joint; MCP III, middle finger metacarpophalangeal joint; MCP IV,
ring finger metacarpophalangeal joint; MCP V, little finger metacarpophalangeal joint.
aIn degrees.
TABLE 3. ACTIVITIES OF DAILY LIVINGa
Eating Personal hygiene
Preoperatively Postoperatively Preoperatively Postoperatively
No problem 0 7 0 3
Some problems 11 6 11 11
Considerable problems 4 2 4 1
g 5 0.59 g 5 0.33
aNumber of patients.
follow-up time. However, a longer follow-up time is cer-
tainly needed to assure permanence of the results after
degradation of the PLA scaffold.
In severely deformed rheumatoid hands (fixed defor-
mity) it may occasionally be difficult to achieve proper
balancing of soft tissues. When a silicone implant is put
in place under compromised circumstances the imbal-
anced stress to the implant and the sharp irregularities
of the resected bones can easily lead to implant break-
age and consequently to recurrence of deformity and
pain as well as loss of function. With bioreconstructive
BIORECONSTRUCTIVE JOINT SCAFFOLD
and bioabsorbable prostheses we can avoid the problems
of broken implants. This type of bioreconstructive im-
plant has no stems but the implant is sutured with bioab-
sorable stitches inside the joint space. Thus the implant
causes no stress and shields the metacarpal diaphysis,
which is valuable especially in cases with major bone
resorption.
In revision arthroplasties the stemless implant also
makes it possible to use intramedullar bone grafting to
fill osteolytic cavities. An example of such a patient with
major bone resorption caused by implant stems preoper-
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TABLE 4. VOLAR SUBLUXATIONa
,2 mm 3–5 mm .6 mm k
MCP II
Preoperatively 4b 5 6
Postoperatively 13b 1 1 20.07
MCP III
Preoperatively 4b 3 6
Postoperatively 9b 4 0 20.14
MCP IV
Preoperatively 2b 3 8
Postoperatively 7b 5 1 20.31
MCP V
Preoperatively 2b 1 10
Postoperatively 4b 8 1 20.09
Abbreviations: See Table 2.
aMeasured from oblique X-rays.
bThe values indicate the number of joints.
FIG. 4. Postoperative photograph at 3-month follow-up (same patient as in Fig. 1), with maximum active extension. Finger
alignment has improved and extension lack reduced. Cosmetic reformation is noticeable.
atively is presented in Fig. 5. In PLA96 arthroplasty the
bone cavities were filled in with allograft bank bone,
PLA96 scaffold was fixed in its place, and all necessary
soft tissue balancing was done. The situation 2 years post-
operatively, when PLA96 is heavily degraded, is shown
in Fig. 6. Remodeling of the bone and thickening of the
cortices can clearly be seen and there is a space between
the metacarpus and proximal phalange, indicating pres-
ent material.
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The balancing of the joint is crucial, and the joint
should be tight enough at the end of the operation to al-
low absorption of the implant without malalignment of
the hand bones. At the clinical examination it was no-
ticed that the MCP joints functioned and glided nearly
like a normal joint and not like a hinge, as is commonly
experienced with silastic implants. None of the joints has
been opened so far, and thus no histological observations
of the quality and quantity of the tissue exist.
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FIG. 5. Preoperative radiograph of a revision arthroplasty case. Swanson arthroplasty was performed 10 years previously. Ex-
tensive thinning of the diaphyseal cortices around the Swanson implant stems can be seen.
FIG. 6. Postoperative radiograph of the same patient 2 years after PLA96 joint scaffold arthroplasty. In the operation in-
tramedullary defects have been filled with autologous bone graft. Postoperative remodeling of the bone and thickening of the
cortices can be observed. “Empty” space between metacarpus and proximal phalanx indicates the location of bioreconstructive
joint scaffold implant and in-grown soft tissue.
Follow-up of the present patients to determine the
long-term results of this new technique of arthroplasty
continue. A check-point at 4 years has been chosen to
confirm the situation for those joints from which PLA96
has been completely disappeared. A randomized prospec-
tive multicenter study using PLA96 joint scaffold and
Swanson implants has also started, to confirm these
promising preliminary results.
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